André Carpentier

Prix et distinctions

• (2025) Canada Research Chair (Tier 1) in Molecular Imaging of Diabetes. Canada Research Chairs (CRC). (Prize / Award).
• (2024) Dean's honor list in 2023 which recognizes outstanding 10% of its professors who are distinguished by their outstanding performance and commitment to the Faculty of Medecine. Université de Sherbrooke. (Honor).
• (2023) Dean's honor list in 2022 which recognizes outstanding 10% of its professors who are distinguished by their outstanding performance and commitment to the Faculty of Medecine. Université de Sherbrooke. (Honor).
• (2022) Dean's honor list in 2021 which recognizes outstanding 10% of its professors who are distinguished by their outstanding performance and commitment to the Faculty of Medecine. Université de Sherbrooke. (Honor).
• (2017) Dean's honor list 2015 which recognizes outstanding 10% of its professors who are distinguished by their outstanding performance and commitment to the Faculty of Medecine. Université de Sherbrooke. (Honor).
• 2011 CSEM Diabetes Young Investigator Award. Canadian Society of Endocrinology and Metabolism. (Distinction).
• 2014 Physician Scientist Award. Canadian Lipoprotein Conference. (Distinction).
• Canadian Diabetes Association – Canadian Institutes of Health Research Institute of Nutrition Metabolism and Diabetes Young Scientist Award. Canadian Diabetes Association. (Distinction).
• Canadian Society of Endocrinology and Metabolism Henry Friesen Lecturer Award. The Canadian Society of Endrocrinology and Metabolism. (Prize / Award).
• Fellow of the Canadian Academy of Health Sciences (CAHS). Canada Academy of Health Sciences (CAHS). (Distinction).
• Grand Prix d’excellence / 13è édition du gala des Prix d'excellence du conseil d'administration du Centre hospitalier universitaire de Sherbrooke. Centre Hospitalier Univ. de Sherbrooke. (Honor).
• Naranjan Dhalla Award for Innovative Investigators in Cardiovascular Sciences. International Academy of Cardiovascular Sciences. (Prize / Award).
• Prix des Fondateurs 2016 de la Société québécoise de lipidologie, nutrition et métabolisme. La Société Québécoise de Lipidologie de Nutrition et de Métabolisme. (Distinction).
• Prix Étienne-LeBel, Cérémonie de reconnaissance du vice-décanat aux études supérieures, à la recherche et à l’innovation de la Faculté de médecine et des sciences de la santé de l’Université de Sherbrooke. Université de Sherbrooke. (Prize / Award).

Financement

• Grant. (Awarded). Principal Investigator. Stimulating adipose tissue fatty acid disposal with low-dose, postprandial, intermittent niacin for the treatment of metabolic dysfunction-associated steatotic liver disease. Canadian Institutes of Health Research (CIHR). Project Grant PJT-195983. 1 197 225 $. (2024-2029)
• Grant. (Awarded). Co-investigator. Maximize your Research in Obesity and Diabetes – myROaD. Canadian Institutes of Health Research (CIHR). Health Research Training Platform RT8-179722. 2 400 000 $. (2022-2028)
• Grant. (Awarded). Principal Applicant. ImagingT2D: Multimodal Imaging Program for Type 2 Diabetes Prevention and Treatment. Canada Foundation for Innovation (CFI). Innovation Funds 2023. 16 437 758 $. (2023-2028)
• Grant. (Awarded). Co-investigator. Documenting the Essential Conditions for Implementing Urban Trails in Canada: A Novel Triangulation Approach. Canadian Institutes of Health Research (CIHR). Project Grant. 1 453 500 $. (2023-2028)
• Grant. (Awarded). Principal Investigator. Improved adipose tissue storage of dietary fatty acids as a new mechanism for the rapid remission of hepatic and cardiac metabolic dysfunction after bariatric surgery. Canadian Institutes of Health Research (CIHR). Project grant. 956 250 $. (2022-2027)
• Grant. (Awarded). Co-investigator. Organ-specific contribution to cold-induced thermogenesis during the development of type 2 diabetes. Diabetes Canada. -. 300 000 $. (2024-2027)
• Grant. (Awarded). Co-investigator. Mobilizing knowledge and implementing equitable and cost-effective health and social care services for persons living with diabetes in Canada (Diabetes Action Canada). Canadian Institutes of Health Research (CIHR). Strategy for Patient-Oriented Research Network. 3 750 000 $. (2022-2026)
• Grant. (Awarded). Principal Investigator. Professionnalisation de la formation en recherche dans le RUISSS de l’Université de Sherbrooke. Fonds de recherche du Québec - Santé (FRQS). Programme TREMPLIN volet 1. 600 000 $. (2023-2026)
• Grant. (Awarded). Co-investigator. Precision medicine study of type 2 diabetes in the COLCOT-T2D trial. Canadian Institutes of Health Research (CIHR). Team Grant : Diabetes Mechanisms and Translational Solutions - General Pool. 2 000 000 $. (2021-2026)
• Grant. (Awarded). Co-applicant. Cardioprotective effect of a cyclic azapeptide ligand of CD36 against ischemia-reperfusion damage and dysfunction in mice. Canadian Institutes of Health Research (CIHR). Project Grant: Fall 2020 and Spring 2021. 726 750 $. (2021-2026)
• Grant. (Awarded). Co-applicant. Genomic study of type 2 diabetes and response to medication. Canadian Institutes of Health Research (CIHR). Project Grant: Fall 2020 and Spring 2021. 1 600 000 $. (2021-2026)
• Grant. (Awarded). Principal Investigator. Appel de projets pour le soutien à l’organisation et à la valorisation des renseignements de santé (mesure de la Stratégie québécoise des sciences de la vie).Organisation et valorisation des données de santé au sein du pôle universitaire de santé.. Ministère de l'Économie et de l'innovation - Québec. Programme de soutien aux organismes de recherche et d’innovation (PSO). 500 000 $. (2023-2026)
• Grant. (Awarded). Principal Investigator. The right timing to prevent type 2 diabetes: restoring 24-hour substrate rhythmicity to improve glycemic control by timing of lifestyle factors. Canadian Institutes of Health Research (CIHR). Team Grant: Netherlands-Canada type 2 diabetes research consortium. 2 000 000 $. (2021-2026)
• Grant. (Awarded). Co-applicant. COLCOT-T2D : Colchicine for primary prevention of cardiovascular events in patients with type 2 diabetes. Canadian Institutes of Health Research (CIHR). Autumn 2019 and spring 2020 - Project grant. 7 120 000 $. (2020-2025)
• Research Chair. (Awarded). Principal Applicant. Canada research chair (tier 1) in molecular imaging of diabetes. Canada Research Chairs (CRC). Canada Research Chair in Molecular Imaging of Diabetes. 1 400 000 $. (2018-2025)
• Grant. (Awarded). Co-applicant. Can online training improve diabetes self-management of adolescents and emerging adults living with type 1 Diabetes? The SUPPORT-ADO project. Canadian Institutes of Health Research (CIHR). Autumn 2019 and spring 2020 - Project grant. 710 000 $. (2020-2025)
• Grant. (Awarded). Co-applicant. Modulating TMPRSS6 activity to impact obesity. Canadian Institutes of Health Research (CIHR). Operating grant. 950 000 $. (2020-2025)
• Grant. (Awarded). Co-investigator. Targeting TMPRSS6 for the modulation of hepcidin. Canadian Institutes of Health Research (CIHR). Autumn 2019 and spring 2020 - Project grant. 1 065 000 $. (2020-2025)
• Grant. (Awarded). Principal Investigator. Organisation et valorisation des données de santé au sein du pôle universitaire de santé numérique de l’Estrie. Ministère des Finances, de l'Économie et de la Recherche (MFER) (Québec). Programme de soutien aux organismes de recherche et d’innovation (PSO). 500 000 $. (2023-2025)
• Grant. (Awarded). Co-investigator. Paradigm shift in the conduct of clinical trials. FACS Ministère de l'Économie, de la Science et de l'Innovation. Paradigm shift in the conduct of clinical trials. 10 000 000 $. (2021-2025)
• Grant. (Awarded). Principal Investigator. Pôle de santé numérique de l'Estrie. Fonds de recherche du Québec - Santé (FRQS). Programme personnel hautement qualifié et intelligence artificielle. 1 319 602 $. (2022-2024)
• Grant. (Awarded). Principal Investigator. Initiative structurale intercentre (« Exploring the use of 11C-acetate positron emission tomography to advance understanding of adaptive thermogenesis – a method-developping study. Fonds de recherche du Québec - Santé (FRQS). Network program (CMDO Network). 40 000 $. (2023-2024)
• Grant. (Completed). Principal Applicant. Quantifying brown adipose tissue thermogenesis in obesity and type 2 diabetes. Canadian Institutes of Health Research (CIHR). Project Scheme. 1 055 700 $. (2018-2023)
• Grant. (Declined). Co-investigator. Imaging microvascularization-related processes in normal brain, Alzheimer's disease, diabetes and cancer. Canada Foundation for Innovation (CFI). Operating grant. 3 141 820 $. (2017-2022)
• Grant. (Declined). Co-applicant. Reduction of cardiac ischemia-reperfusion injury through modulatory effect of cyclic CD36 azapeptide ligand on PPAR-? activation and alteration of macrophage polarization in a mouse model. Heart and Stroke Foundation of Canada (HSFC). Grant in aid. 300 000 $. (2019-2022)
• Grant. (Completed). Co-investigator. BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes: The BETTER study. Canadian Institutes of Health Research (CIHR). BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes: The BETTER study. 1 500 000 $. (2018-2022)
• Grant. (Completed). Co-investigator. Curbing atherosclerosis through precision medecine. FACS - Ministère de l'Économie, de la Science et de l'Innovation. Curbing Atherosclerosis Through Precision Medecine. 26 305 015 $. (2018-2022)
• Grant. (Completed). Co-investigator. Regulation of adipose tissue Thermogenesis by IGFBP2. Canadian Institutes of Health Research (CIHR). Project Scheme. 959 450 $. (2016-2021)
• Grant. (Completed). Principal Investigator. Investigation of postprandial fatty acid metabolism in the natural history of type 2 diabetes mellitus (T2D). Canadian Institutes of Health Research (CIHR). Operating grant. 241 472 $. (2020-2021)
• Grant. (Completed). Principal Applicant. Réseau de la recherche en santé cardio-métabolique, diabète et obésité (CMDO). Fonds de recherche du Québec - Santé (FRQS). Création d'un réseau thématique de recherche. 2 280 000 $. (2017-2021)
• Research Chair. (Completed). Principal Investigator. Rôle des microARNs dans le métabolisme des acides gras alimentaires du diabète de type 2. CMDO Réseau de Recherche en Santé Cardiométabolique, Diabète et Obésité. Initiative structurale intercentre. 40 000 $. (2020-2021)
• Grant. (Completed). Co-applicant. SPOR Network in diabetes and its Related Complications. Caprion Proteomics Inc.. Operating grant. 12 500 000 $. (2016-2021)
• Grant. (Declined). Principal Applicant. Impact of high exposure to free fatty acids on in vivo androgenic biosynthesis in women who resolved their polycystic ovary syndrome after weight loss. Canadian Institutes of Health Research (CIHR). Operating grant. 660 000 $. (2017-2020)
• Grant. (Completed). Principal Applicant. Netherlands-Canada type 2 diabetes consortium. Canadian Institutes of Health Research (CIHR). Travel award. 2 500 $. (2019-2020)
• Grant. (Declined). Co-applicant. Role of lipotoxicity in hyperandrogenism with in vivo and in vitro impacts of angiotensin II type 2 receptor and PPAR gamma agonists. Canadian Institutes of Health Research (CIHR). Operating grant. 980 000 $. (2017-2020)
• Grant. (Declined). Co-applicant. Targeting CD36 to treat age-related macular degeneration. Canadian Institutes of Health Research (CIHR). Operating grant. 400 000 $. (2017-2020)
• Grant. (Declined). Co-applicant. Thermogenic and other cellular metabolic mechanisms induced by acute and chronic cold exposure in humans. Canadian Institutes of Health Research (CIHR). Operating grant. 1 200 000 $. (2017-2020)
• Grant. (Completed). Co-investigator. Decrypting the gut microbiome to identify new therapies for NAFLD in children and adults. Canadian Institutes of Health Research (CIHR). Team grant: Canadian Microbiome Initiative 2: A Focus on Function and Translation Research Teams – L. 25 000 $. (2019-2019)
• Grant. (Declined). Co-investigator. Correction de mouvement pré-reconstruction (CMPR) d’image cérébral TEP et réduction de dose d’exposition du participant à la radiation TDM (CT-scan). Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke Inc. (CRCHUS) (Sherbrooke, QC). PAFI. 25 000 $. (2016-2018)
• Grant. (Completed). Principal Investigator. Activation pharmacologique de la graisse brune chez l’humain. Merck Sharp & Dohme Research Laboratory. Merck's grant program through the Faculty of Medecine of University of Sherbrooke. 173 095 $. (2016-2018)
• Grant. (Completed). Principal Applicant. Améliorer la prédiction des issues cliniques du diabète de type 2 à l’aide de l'imagerie moléculaire. Infrastructure du gouvernement du Québec. MESI. 3 999 330 $. (2017-2018)
• Research Chair. (Completed). Principal Investigator. GSK Chair in Diabetes of University of Sherbrooke. GlaxoSmithKline. Chair of Diabetes of University of Sherbrooke. 750 000 $. (2016-2018)
• Grant. (Completed). Principal Applicant. Développement d'un système automatisé de clamp de la température cutanée compatible à l'IRM. Centre d'imagerie moléculaire de Sherbrooke. Programme de projets pilotes AIM/CIMUS. 10 000 $. (2018-2018)
• Grant. (Completed). Principal Applicant. Évaluation du niveau d’expression de gènes d’adipocytes ayant le potentiel d’affecter le développement du diabète: validation expérimentale d’une prédiction bioinformatique. Fonds de recherche du Québec - Santé (FRQS). Subvention intercentre du Réseau CMDO. 10 000 $. (2016-2018)
• Grant. (Completed). Principal Investigator. Centre d'excellence de l'université de Sherbrooke sur le recherche sur le diabète, l’obésité et les complications cardiovasculaires de l’université de Sherbrooke (CEUS DOCC). University of Sherbrooke. Centre d'excellence de l'Université de Sherbrooke. 375 000 $. (2015-2017)
• Grant. (Completed). Co-investigator. Validation d’un compteur microfluidique pour la mesure de la fonction d’entrée en analyse pharmacocinétique chez le petit animal. Centre d'imagerie moléculaire de Sherbrooke. Programme de projets pilotes AIM/CIMUS. 9 995 $. (2016-2017)

Publications

Articles de revue

• Arsenault BJ, Carpentier AC, Poirier P, Després JP. (2024). Adiposity, type 2 diabetes and atheroscleroticcardiovascular disease risk : Use and abuse of the body mass index. Atheroslerosis - (-), -. (Published).
• Blondin DP, Haman F, Swibas TM, Hogan-Lamarre S, Dumont L, Guertin J, Richard G, Weissenberger Q, Hildreth KL, Schauer IE, Panter S, Wayland L, Carpentier AC, Miao Y, Shi J, Jaruez-Colunga E, Kohrt WM, Melanson EL. (2024). Brown Adipose Tissue Metabolism in Women is Dependent on Ovarian Status. AM J Physiol Endocrinol Metab 326 (5), 588-601. (Published).
• St-Pierre V, Richard G, Croteau E, Fortier M, Vandenberghe C, Carpentier AC, Cuenoud B, Cunane SC. (2024). Cardiorenal ketone metabolism in healthy humansassessed by 11C-acetoacetate PET: effect of D-β-hydroxybutyrate, ameal, and age. Front Physiol (Published).
• Caron A, Carpentier AC, Deshaies Y, Després JP, Picard F, Rivest S, Tchenof A. (2024). In Memoriam : Denis Richard 1953-2023. Neuroendocrinology 114 (4), 313-314. (Published).
• Carpentier AC, Blondin DP. (2024). Is stimulation of browning of human adipose tissuea relevant therapeutic target?. Ann Endocrinol (Paris) 85 (3), 184-189. (Published).
• Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, Carpentier AC. (2024). Plasma endocannabinoids are independently associated with the metabolicfunction of white adipose tissue. J Clin Endocrinol Metab - (-), -. (In Press).
• Slebe R, Wenker, E, Shoonmade LJ, Bouman EJ, Blondin DP, Campbell DJT, Carpentier AC, Hoeks J, Raina P, Schrauwen P, Serlie MJ, Stenvers DJ, de Mutsert R, Beulens JWJ, Rutters F. (2024). The effect of preprandial versus postprandialphysical activity of glycaemia: Meta-analysis of human intervention studies. Diabetes Res Clin Pract - (-), -. (Published).
• Dumont L, Caron A, Richard G, Croteau E, Fortin M, Frisch F, Phoenix S, Dubreuil S, Guérin B, Turcotte EE, Carpentier AC, Blondin DP. (2024). The effect of the β1 – adrenergicreceptor antagonist bisoprolol administration on mirabegron – stimulated humanbrown adipose tissue thermogenesis. Acta Physiol (Oxf) 240 (5), -. (Published).
• Carpentier A. (2024). Tracer sand imaging of fatty acid and energy metabolism of human adipose tissues. Physiology (Bethesda) 39 (2), (Published).
• Ye RZ*, Montastier E, Frisch F, Noll C, Allard-Chamard H, Gevry N, Tchernof A, Carpentier AC. (2024). in vivoAdipocyte hypertrophy associates with postprandial fatty acid metabolism and adipose single-cell transcriptionaldynamics. iScience 27 (1), -. (Published).
• Carpentier AC, Blondin DP, Haman F, Richard D. (2023). Brown Adipose Tissue-A Translational Perspective. Endocr Rev. 44 (2), 143-192. (Published).
• Cuenoud B, Croteau E, St-Pierre V, Richard G, Fortier M, Vandenberghe C, Carpentier AC, Cunnane SC. (2023). Cardiorenal ketone metabolism: a positron emission tomography study in healthy humans. Front Physio 14 -. (Published).
• Carpentier AC, Blondin DP. (2023). Human brown adipose tissue is not enough to combat cardiometabolic diseases. J Clin Invest. 133 (23), e175288. (Published).
• Shang R, Syng Lee C, Wang H, Dyer R, Noll C, Carpentier AC, Sultan I, Alitalo K, Boushel R, Hussein B, Rodrigues B. (2023). Reduction in Insulin Uncovers a Novel Effect of VEGFB on Cardiac Substrate Utilization. Arteriosclerosis, Thrombosis and Vascular Biology. 44 (1), 177-191. (Published).
• Behzadi P, Ravanelli N, Gravel H, Barry H, Debray A, Chaseling Georgia K, Jacquemet V, Neagoe PE, Nigam A, Carpentier AC, Sirois MG, Gagnon D. (2022). Acute effect of passive heat exposure on markersof cardiometabolic function in adults with type 2 diabetes mellitus. J Appli Physiol (1985) 132 (5), 1154-1166. (Published).
• Grenier-Larouche T*, Coulter Kwee L, Deleye Y, Leon-Mimila P, Walejko JM, McGarrah RW, Marceau S, Trahan S, Racine C, Carpentier AC, Lusis AJ, Ilkayeva O, Vohl MC, Huertas-Vazquez A, Tchernof A, Shah SH, Newgard CB, White PJ. (2022). Altered branched-chain a-ketoacid metabolism is a feature of NAFLD in individuals with severe obesity. JCI Insight 7 (15), -. (Published).
• Ye RZ*, Noll C, Richard G, Lepage M, Turcotte EE, Carpentier AC. (2022). DeepImage Translator: A free, user-friendly graphical interface forimage translation using deep-learning and its applications in 3D CT image analysis. SLAS Technol. 27 (1), 76-84. (Published).
• Ye RZ*, Richard G*, Gévry N, Tchernof A, Carpentier AC. (2022). Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships with Metabolic Dysregulations. Endocrine Reviews 43 (1), 35-60. (Published).
• Richard G*, Blondin DP, Syed SA, Rossi L, Fontes ME, Fortin M, Phoeniex S, Frisch F, Dubreuil S, Guérin B, Turcotte EE, Lepage M, Surette MG, Shcertzer JD, Steingerg GR, Morrison KM, Carpentier AC. (2022). High Fructose feeding suppresses cold-stimulated brownadipose tissue glucose uptake independently of changes in thermogenesis and thegut microbiome. Cell Rep Med. 3 (9), -. (Published).
• Ahmed BA, Varah N, Ong FJ, Blondin DP, Gunn E, Konyer NB, Singh NP, Noseworthy MD, Haman F, Carpentier AC, Punthakee Z, Steinberg GR, Morrison KM. (2022). Impaired Cold Stimulated Supraclavicular Brown Adipose Tissue Activity in Young Boyswith Obesity. Diabetes 71 (6), 1193-1204. (Published).
• Brazeau AS, Messier V, Talbo MK, Gagnon C, Taleb N, fortier I, Wu Z, Perkins BA, Carpentier AC, Bandini A, Rabasa-Lhoret R; BETTER Study Group. (2022). Self-reported Severe and Nonsevere Hypoglycemia in Type 1 Diabetes: Population Surveillance Through theBETTER Patient Engagement Registry: Development and Baseline Characteristics. Can J Diabetes 46 (8), 813-821. (Published).
• Girard R, Tremblay S, Noll C, St-Jean S, Jones C, Gélinas Y, Maloum-Rami F, Perreault N, Laplante M, Carpentier AC, Boudreau F. (2022). The transcription factor hepatocyte nuclear factor 4A acts in the intestine to promote white adipose tissue energy storage. Nat Commun. 13 (1), 224. (Published).
• Ye RZ*, Montastier E*, Noll C, Frisch F, Fortin M, Bouffard L, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. (2022). Total postprandial Hepatic Non-Esterified and Dietary Fatty Acid Uptake is Increased and Insufficiently Curbedby Adipose Tissue Fatty Acid Trapping in Prediabetes with Overweight. Diabetes 71 (9), 1891-1901. (Published).
• Kastner M, Makarski J, Seaton MB, Sedig K, Bélanger M, Carpentier AC, Gaudreau A, Lourido G, Murray M, Dainty KN. (2022). Training the next generation of diabetes researchers:Evaluation of the Diabetes Action Canada Training & Mentoring Program. Canadian Journal of Diabetes 46 (8), 776-788. (Published).
• Carpentier AC. (2021). 100th Anniversary of the Discovery of Insulin Perspective: Insulin and Adipose Tissue Fatty Acid Metabolism. Am J Physiol Endocrinol Metab 320 (4), E653-E670. (Published).
• Richard G*, Noll C, Archambault M, Lebel R, Tremblay L, Ait-Mohand S, Guérin B, Blondin DP*, Carpentier AC, Lepage M. (2021). Contribution of Perfusion to the 11C-Acetate Signal in Brown Adipose Tissue Assessed by DCE-MRI and 68Ga-DOTA PET in a Rat Model. Magn Reson Med 85 (3), 1625-1642. (Published).
• Lewis GF, Carpentier AC, Pereira S, Hahn M, Giacca A. (2021). Direct and Indirect Control of Hepatic Glucose Production by Insulin. Cell Metab 33 (4), 709-720. DOI. (Published).
• Faramia J, Hao Z, Mumphrey MB, Townsend RL, Miard S, Carreau AM*, Nadeau M, Frisch F, Baraboi ED, Grenier-Larouche T*, Noll C, Li M, Biertho L, Marceau S, Hould FS, Lebel S, Morrison CD, Münzberg H, Richard D, Carpentier AC, Tchernof A, Berthoud HR, Picard F. (2021). IGFBP-2 Partly Mediates the Early Metabolic Improvements Caused by Bariatric Surgery. Cell Rep Med 2 (4), 100248. (Published).
• Montastier É*, Ye RZ*, Noll C, Bouffard L, Fortin M, Frisch F, Phoenix S, Guérin B, Turcotte EE, Lewis G, Carpentier AC. (2021). Increased Postprandial Nonesterified Fatty Acid Efflux from Adipose Tissue in Prediabetesis Offset by Enhanced Dietary Fatty Acid Adipose Trapping. Am J Physiol Endocrinol Metab 6 (320), 1093-1106. (Published).
• Ahmed BA, Ong FJ, Barra NG, Blondin DP, Gunn E, Oreskovich SM, Szamosi JC, Syed SA, Kutchings EK, Konyer NB, Singh NP, Yabut JM, Desjardins EM, Anhé FF, Foley KP, Holooway AC, Noseworthy MD, Haman F, Carpentier AC, Surette MG, Schertzer JD, Punthakee Z, Steinberg GR, Morrison KM. (2021). Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota. Cell Rep Med 2 (9), 0-0. DOI. (Published).
• Després JP, Carpentier AC, Tchernof A, Neeland IJ, Poirier P. (2021). Management of Obesity in Cardiovascular Practice : JACC Focus Seminar. J Am Coll Cardiol. 78 (5), 513-531. (Published).
• Diallo K, Dussault S, Noll C, Lopez AF, Rivard A, Carpentier AC, Lim GE. (2020). 14-3-3ζ Mediates an Alternative, Non-Thermogenic Mechanism in Male Mice to Reduce Heat Loss and Improve Cold Tolerance. Molecular Metabolism 41 101052. (Published).
• Poursharifi P, Attané C, Mugabo Y, Al-Mass A, Ghosh A, Schmitt C, Zhao S, Guida J, Lussier R, Erb H, Chenier I, Peyot ML, Joly E, Noll C, Carpentier AC, Madiraju SRM, Prentki M. (2020). Adipose ABHD6 Regulates Tolerance to Cold and ThermoenicPrograms. JCI Insights 5 24. (Published).
• Turcotte AF, Grenier-Larouche T, Lacombe J, Carreau AM*, Carpentier AC, Mac-Way F, Tchernof A, Richard D, Biertho L, Lebel S, Marceau S, Ferron M, Gagnon C. (2020). Association Between Changes in Bioactive Osteocalcin and Glucose Homeostasis after Biliopancreatic Diversion. Endocrine 69 (3), 526-535. (Published).
• Carreau AM*, Noll C, Blondin DP*, Frisch F, Nadeau M, Pelletier M, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Lebel S, Biertho L, Tchernof A, Carpentier AC. (2020). Bariatric Surgery Rapidly Decreases Cardiac Dietary Fatty Acid Partitioning and Hepatic Insulin Resistance Through Increased Intra-abdominal Adipose Tissue Storage and Reduced Spillover in Type2 Diabetes. Diabetes 69 (4), 567-577. (Published).
• Carpentier AC. (2020). Branched Chain Amino Acid Catabolism by Brown Adipose Tissue. Endocrinology 161 7. (Published).
• Blondin DP*, Nielsen S, Kuipers EN, Severinsen MC, Jensen VH, Miard S, Jespersen NZ, Kooijman S, Boon MR, Fortin M, Phoenix S, Frisch F, Guérin B, Turcotte ÉE, Haman F, Richard D, Picard F, Rensen PCN, Scheele C, Carpentier AC. (2020). Human Brown Adipocyte Thermogenesis is Driven by β2-AR Stimulation. Cell Metabolism 32 (2), 287-300. (Published).
• Baillargeon JP, St-Cyr-Ribble D, Xhignesse M, Brown C, Carpentier AC, Fortin M, Grant A, Simoneau-Roy J, Langlois MF. (2020). Impact of an Educational Intervention Combining Clinical Obesity Preceptorship with Electronic Networking Tools on Primary CareProfessionals: Prospective Study. BMC Med Educ 20 (1), 361. (Published).
• Lacombe J, Al Rifai O, Loter L, Moran T, Turcotte AF, Grenier-Larouche T*, Tchernof A, Biertho L, Carpentier AC, Prud'homme D, Rabasa-Lhoret R, Karsenty G, Gagnon C, Jiang W, Ferron M. (2020). Measurement of Bioactive Osteocalcin in Humans Usinga Novel Immunoassay Reveals Association with Glucose Metabolism and β-cell Function. Am J Physiol Endocrinol Metab 318 (3), E-381-E391. (Published).
• Cuenoud B, Hartweg M, Godin JP, Croteau E, Maltais M, Castellano CA, Carpentier AC, Cunnane SC. (2020). Metabolism of Exogenous D-Beta-Hydroxybutyrate, an Energy Substrate Avidly Consumed by the Heart and Kidney. Front Nutr 7 13. (Published).
• Noll C, Montastier É*, Amrani M, Kunach M*, Frisch F, Fortin M, Bouffard L, Dubreuil S, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Laville M, Carpentier AC. (2020). Seven-day Overfeeding Enhances Adipose Tissue Dietary Fatty Acid Storage and Decreases Myocardial andMuscle Dietary Fatty Acid Partitioning in Healthy Subjects. AM J Physiolol endocrinol Metab 318 (2), E286-E296. DOI. (Published).
• Huynh DN, Elimam H, Bessi VL, Ménard L, Burelle Y, Granata R, Carpentier AC, Ong H, Marleau S. (2019). A Linear Fragment of Unacylated Ghrelin (UAG6-13) Protects AgainstMyocardial Ischemia/Reperfusion Injury in Mice in a Growth Hormone SecretagogueReceptor-Independent Manner. Frontiers in Endocrinology (Lausanne) 9 798. (Published).
• Bourgeois R, Piché ME, Auclair A, Grenier-Larouche T*, Mitchell PL, Poirier P, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Lescelleur O, Julien F, Martin J, Tchernof A, Mathieu P, Carpentier AC, Arsenault BJ. (2019). Acute and chronic effect of bariatric surgery on circulating autotaxin levels. Physiological Reports 7 (5), 14004. (Published).
• Richard MA*, Blondin DP*, Noll C, Lebel R, Lepage M, Carpentier AC. (2019). Determination of a pharmacokinetic model for [11C]-acetate in brown adipose tissue. EJNMMI Res. 9 (1), 31. (Published).
• Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T, Carpentier AC. (2019). Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet 394 ((10193)), 121-130. (Published).
• Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T, Carpentier AC. (2019). Dulaglutide and renal outcomes in type 2 diabetes: anexploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet 394 ((10193)), 131-138. (Published).
• Turcotte AF, Grenier-Larouche T*, Ung RV, Simonyan D, Carreau AM*, Carpentier AC, Mac-Way F, Michou L, Tchernof A, Biertho L, Lebel S, Marceau S, Gagnon C. (2019). Effects of Bilipancreatic Diversion on Bone Turnover markers and Association with Hormonal Factors in Patients with Severe Obesity. Obes Surg 29 (3), 990-998. (Published).
• Taleb N, Carpentier AC, Messier V, Ladouceur M, Haidar A, Rabasa-Lhoret R. (2019). Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using IntensiveInsulin Therapy: A Randomized Crossover Pilot Trial. Diabetes Care 42 (7), e107-e109. (Published).
• Girard R, Darsigny M, Jones C, Maloum-Rami F, Gélinas Y, Carpentier AC, Laplante M, Perreault N, Boudreau F. (2019). HNF4? is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide. Scientific Reports 9 (1), 4200. (Published).
• Oreskovich SM, Ong FJ, Ahmed BA, Konyer NB, Blondin DP*, Gunn E, Singh NP, Noseworthy MD, Haman F, Carpentier AC, Punthakee Z, Steinberg GR, Morrison KM. (2019). MRI Reveals Human Brown Adipose Tissue is Rapidly Activated in Response to Cold. Journal of Endocrinology Society 3 (12), 2374-2384. (Published).
• Petrus P, Fernandez TL, Kwon MM, Huang JL, Lei V, Safikhan NS, Karunakaran S, O'Shannessy DJ, Zheng X, Catrina SB, Albone E, Laine J, Virtanen K, Clee SM, Kieffer TJ, Noll C, Carpentier AC, Johnson JD, Rydén M, Conway EM. (2019). Specific Loss of Adipocyte CD248 Improves Metabolic Health via Reduced White Adipose Tissue Hypoxia, Fibrosis and Inflammation. EBioMedicine 44 489-501. (Published).
• Carpentier AC. (2018). Abnormal myocardial dietary fatty acid metabolism and diabetic cardiomyopathy. Canadian Journal of Cardiology 34 (5), 605-614. (Published).
• Huynh DN, Bessi VL, Ménard L, Piquereau J, Proulx C, Febbraio M, Lubell WD, Carpentier AC, Burelle Y, Ong H, Marleau S. (2018). Adiponectin has a pivotal role in the cardioprotective effect of CP-3(iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in mice. FASEB Journal 32 (2), 807-818. (Published).
• Carpentier AC, Blondin DP*, Virtanen KA, Richard D, Haman F, Turcotte ÉE. (2018). Brown Adipose Tissue Energy Metabolism in Humans. Frontiers in Endocrinology 9 447. (Published).
• Barrière DA, Noll C, Roussy G, Lizotte F, Kessai A, Kirby K, Belleville K, Beaudet N, Longpré JM, Carpentier AC, Geraldes P, Sarret P. (2018). Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications. Scientific Reports 8 (1), 424. doi: 10.1038/s4. (Published).
• Bouchouirab FZ*, Fortin M, Noll C, Dubé J, Carpentier AC. (2018). Plasma Palmitoyl-Carnitine (AC16:0) is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Individuals with Type 2 Diabetes. Can J Diabetes 42 (4), 382-388. (Published).
• Ong F, Ahmed B, Oreskovich S, Blondin DP*, Haq T, Konyer N, Noseworthy M, Haman F, Carpentier AC, Morrison K, Steinberg G. (2018). Recent advances in the detection of brown adiposetissue in adult humans: a review. Clinical Science 132 (10), 1039-1054. (Published).
• Boyer M, Piché ME, Auclair A, Grenier-Larouche T*, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Lescelleur O, Julien F, Martin J, Tchernof A, Carpentier AC, Poirier P, Arsenault BJ. (2017). Acute and chronic impact of bariatric surgery on LDL cholesterol and PCSK9 levels in patients with severe obesity. Journal of Clinical Endocrinology and Metabolism 102 4023-4030. (Published).
• Michaud A, Grenier-Larouche T*, Caron-Dorval D, Marceau S, Biertho L, Simard S, Richard D, Tchernof A, Carpentier AC. (2017). Biliopancreatic diversion with duodenal switch leads to better postprandial glucose level and beta cell function than sleeve gastrectomy in individuals with type 2 diabetes very early after surgery. Metabolism 74 10-21. (Published).
• Barrière DA, Noll C, Roussy G, Lizotte F, Kessai A, Kirby K, Belleville K, Beaudet N, Longpré JM, Carpentier AC, Geraldes P, Sarret P. (2017). Combination of high-fat/high-fructose diet andlow-dose streptozotocin to model long-term type-2 diabetes complications. Scientific Reports 8 424. doi: 10.1038/s4. (Published).
• Noll C*, Carpentier AC. (2017). Dietary fatty acid metabolism in pre-diabetes. Current Opinion in Lipidology 1 1-10. (Published).
• Blondin DP*, Tingelstad HC, Noll C, Frisch F, Phoenix S, Guérin B, Turcotte EE, Richard D, Haman F, Carpentier AC. (2017). Dietary fatty acid metabolism of brown adipose tissue in cold-acclimated men. Nature Communications 8 14146. (Published).
• Grenier-Larouche T*, Carreau AM*, Carpentier AC. (2017). Early metabolic improvement after bariatric surgery: the first steps toward type 2 diabetes remission. Canadian Journal of Diabetes 16 S1499-2671. (Published).
• Grenier-Larouche T*, Carreau AM*, Geloën A, Frisch F, Biertho L, Marceau S, Lebel S, Hould FS, Richard D, Tchernof A and Carpentier AC. (2017). Fatty acid metabolic remodelling during type 2 diabetes remission after bariatric surgery. Diabetes 66 2743-2755. (Published).
• Blondin DP*, Daoud A, Taylor T, Tingestald HC, Bézaire V, Richard D, Carpentier AC, Taylor AW, Harper ME, Aguer C, Haman F. (2017). Four-week cold acclimation in adult humans shifts uncoupling thermogenesis from skeletal muscles to brown adipose tissue. Journal of Physiology 595 (6), 2099-2113. (Published).
• St-Jean M*, Boudreau F, Carpentier AC, Hivert MF. (2017). HNF1? defect influences post-prandial lipid regulation. PLoS One 12 (5), e0177110. (Published).
• Tricot B, Descoteaux M, Dumont M, Chagnon F, Tremblay L, Carpentier AC, Lesur O, Lepage M, Lalande A. (2017). Improving the evaluation of cardiac function in ratsat 7T with denoising filters: a comparison study. BMC Medical Imaging 17 ((1)), 62. (Published).
• Blondin DP*, Frisch F, Phoenix S, Guérin B, Turcotte EE, Haman F, Richard D, Carpentier AC. (2017). Inhibition of intracellular triglyceride lipolysis suppresses cold-induced brown adipose tissue metabolism and increases shivering in humans. Cell Metab 25 (2), 438-447. (Published).
• Schrauwen Hinderling VB, Carpentier AC. (2017). Molecular imaging of postprandial metabolism. J. Appl Physiol. 11:jap.00212.2017 ap.00212.2017. (Published).
• Chénard T*, Guénard F, Vohl MC, Carpentier AC, Tchernof A, Najmanovich R. (2017). Remodeling adipose tissue through in silico modulation of fat storage for the prevention of type 2 diabetes. BMC Systems Biology 11 60. (Published).
• Ramanathan S, Lacraz G, Rakotoarivelo V, Labbé S*, Vernier M, Noll C*, Mayhue M, Stankova J, Schwertani A, Grenier G, Carpentier AC, Richard D, Ferbeyre G, Fradette J, Rola-Pleszczynski M, Menendez A, Langlois MF; Ilangumaran S. (2016). Deficiency of interleukin-15 confers resistance to obesity by diminishing inflammation and enhancing the thermogenic function of adipose tissues. Plos One 11 (9), e0162995. (Published).
• Ruiza M, Coderre L, Lachance D, Martel C, Thompson Legault J.Gillis MA, Bouchard B, Daneault C, Carpentier AC, Gaestel M, Allen BG, DesRosiers C. (2016). MK2 deletion in mice prevents diabetes-induced perturbations in lipid metabolism and cardiac dysfunction. Diabetes 65 (2), 381-92. (Published).
• Carpentier AC. (2016). Targeting the gut to treat obesity and its metabolic comorbidities – focus on bariatric surgery:view from the chair. International Journal of Obesity Supplements S1–S2. (Published).
• Blondin DP*, Carpentier AC. (2016). The role of BAT in cardiometabolic disorders and aging. Best Practice & Research Clinical Endocrinology & Metabolism 30 (4), 497-513. (Published).
• Blondin DP*, Labbé SM*, Turcotte E, Haman F, Richard D, Carpentier AC. (2015). A critical appraisal of brown adipose tissue metabolism in humans. Clinical Lipidology 10 (3), 259-80. (Published).
• Carpentier AC. (2015). Acute adaptation of energy expenditure predicts diet-induced weight loss: revisiting the thrifty phenotype (invited commentary). Diabetes 64 (8), 2714-6. (Published).
• Blondin DP*, Labbé SM*, Phoenix S, Guérin B,Turcotte EE, Richard D, Carpentier AC, Haman F. (2015). Contributions of white and brown adipose tissues and skeletal muscles to acute cold-induced metabolic responses in healthy men. Journal of Physiology 593 (3), 701-14. (Published).
• Kunach M*, Noll C*, Phoenix S, Guérin B, Baillargeon JP, Turcotte EE, Carpentier AC. (2015). Effect of Sex and Impaired Glucose Tolerance on Organ-Specific Dietary Fatty Acid Metabolism in Humans. Diabetes 64 (7), 2432-41. (Published).
• Bellanger S; Benrezzak O, Battista MC, Naimi F, Labbe SM*, Frisch F, Normand-Lauzière F*, Gallo-Payet N, Carpentier AC et Baillargeon J P. (2015). Experimental dog model for assessment of fasting and postprandial fatty acid metabolism: pitfalls and feasibility. SAGE Journals 49 (3), 228-40. (Published).
• Carpentier AC. (2015). Hypertriglyceridemia Associated With Abdominal Obesity: Getting Contributing Factors Into Perspective. Arterioscler Thromb Vasc Biol 35 (10), 2076-8. (Published).
• Richard D, Labbé SM*, Caron A, Bakan I, Laplante M, Carpentier AC, Lecomte R. (2015). In vivo measurement of energy substrate contribution to cold-induced brown adipose tissue thermogenesis. Faseb Journal 29 (5), 2046-58. (Published).
• Grenier-Larouche T*, Galinier A, Casteilla L, Carpentier AC, Tchernof A. (2015). Omental Adipocyte Hypertrophy relates to Coenzyme Q10 Redox State and Lipid Peroxidation in Obese Women. Journal of lipid Research 56 (10), 1985-92. (Published).
• Noll C*, Labbé SM*, Pinard S, Shum M, Bilodeau L, Chouinard L, Phoenix S, Lecomte R, Carpentier AC, Gallo-Payet N. (2015). Postprandial fatty acid uptake and adipocytes remodeling in angiotensin type 2 receptor-deficient mice fed a high-fat/high-fructose diet. Adipocyte 5 43-52. (Published).
• Blondin DP*, Labbé SM*, Noll C*, Kunach M*, Phoenix S, Guérin B, Turcotte É, Haman F. Richard D, Carpentier AC. (2015). Selective impairment of glucose, but not fatty acid or oxidative metabolism in brown adipose tissue of subjects with type 2 diabetes. Diabetes 64 (4), 2388-97. (Published).
• Noll C*, Kunach M*, Frisch F, Bouffard L, Dubreuil S, Jean-Denis F, Phoenix S, Cunnane S, Guérin B, Turcotte E, Carpentier A. (2015). Seven-day caloric and saturated fat restriction increases myocardial dietary fatty acid partitioning in impaired glucose-tolerant subjects. Diabetes 64 (11), 3690-9. (Published).
• Thibault V, Morrisset AN, Brown C, Carpentier AC, Baillargeon JP, Langlois MF, Gagnon C*. (2015). The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and ?-cell function. British Journal of Nutrition 1 (2), 161-8. (Published).
• Croteau É, Tremblay S, Gascon S, Dumulon-Perreault V, Langlois R, Labbé SM*, Rousseau JA, Cunnane SC, Carpentier AC, Bénard F, Lecomte R. (2014). 11C-Acetoacetate PET imaging: a potential early marker for cardiac heart failure. Nuclear Medicine and Biology 41 (10), 863-70. (Published).
• Leblanc S, Battista MC, Noll C*, Hallberg A, Gallo-Payet N, Carpentier AC, Vine DF, Baillargeon JP. (2014). Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome. Endocrinology 155 (9), 3684-93. (Published).
• Anderson TJ , Grégoire J , Hegele RA , Couture P , Mancini GB , McPherson R , Francis GA , Poirier P , Lau DC , Grover S , Genest J , Carpentier AC & al. (2014). Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel. The Canadian Journal of Cardiology 30 (4), 377-80. (Published).
• Plourde CE*, Grenier Larouche T*, Caron-Dorval D, Biron S, Marceau S, Lebel S, Biertho L, Tchernof A, Richard D, Carpentier AC. (2014). Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction. Obesity 22 (8), 1838-46. (Published).
• Genest J, Hegele R, Bergeron J, Brophy J, Carpentier AC, Couture P, Davignon J, Dufour R, Frohlich J, Gaudet D, Gupta M, Krisnamoorthy P, Mancini j, McCrindle B, Raggi P, Ruel I, and St-Pierre J. (2014). Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia. Canadian Journal of Cardiology 30 (12), 1471-81. (Published).
• Lacerte G , Langlois MF , Doyon M , Brown C , Carpentier AC , Hivert MF. (2014). Differential Impact of Changes in Adiposity Distribution on Insulin Resistance and Adiponectin Variations Over 4 Years in Normal Weight Young Adults. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 46 (5), 354-9. (Published).
• Gagnon C, Daly RM, Carpentier AC, Lu ZX, Shore-Lorenti C, Sikaris K, Jean S, Ebeling PR. (2014). Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and ?-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PlosOne 9 ((10)), e109607. (Published).
• Labbé SM*, Noll C*, Grenier-Larouche T*, Bouffard, L, Phoenix S, Guerin B, Baillargeon JP, Langlois MF, Turcotte É, Carpentier AC. (2014). Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance. Am J Physiol Endocrinol Metab 306 (12), E1388-96. (Published).
• Blondin DP*, Labbé SM*, Christian Tingelstad H , Noll C*, Kunach M*, Phoenix S, Guérin B , Turcotte EE , Carpentier AC , Richard D , Haman F. (2014). Increased brown adipose tissue oxidative capacity in cold-acclimated humans. The Journal of Clinical Endocrinology and Metabolism 99 (3), E438-46. (Published).
• Veilleux A , Grenier E , Marceau P , Carpentier AC , Richard D , Levy E. (2014). Intestinal Lipid Handling: Evidence and Implication of Insulin Signaling Abnormalities in Human Obese Subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 34 (3), 644-53. (Published).
• Pereira S, M. Breen D, E. Naassan A, Y.T. Wang P, Uchino H, Fantus G, Carpentier AC, Gutierrez-Juarez R,. Brindley D, Lam T, Giacca A. (2014). In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity. Metabolism 64 (2), 315-22. (Published).
• Biet M , Morin N , Benrezzak O , Naimi F , Bellanger S , Baillargeon JP , Chouinard L , Gallo-Payet N , Carpentier AC , Dumaine R. (2014). Lasting alterations of the sodium current by short-term hyperlipidemia as a mechanism for initiation of cardiac remodeling. American Journal of Physiology. Heart and Circulatory Physiology 306 (2), H291-7. (Published).
• Dutia R , Brakoniecki K , Bunker P , Paultre F , Homel P , Carpentier AC , McGinty J , Laferrère B. (2014). Limited recovery of ?-cell function after gastric bypass despite clinical diabetes remission. Diabetes 63 (4), 1214-23. (Published).
• Dutia R , Brakoniecki K , Bunker P , Paultre F , Homel P , Carpentier AC , McGinty J , Laferrère B. (2014). Response to Comment on Dutia et al. Limited Recovery of ?-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission. Diabetes 2014;63:1214-1223. Diabetes 63 (4), e4. (Published).
• Anderson TJ , Grégoire J , Hegele RA , Couture P , Mancini GB , McPherson R , Francis GA , Poirier P , Lau DC , Grover S , Genest J , Carpentier AC & al. (2013). 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. The Canadian journal of Cardiology 29 (2), 151-67. (Published).
• Forget G , Doyon M , Lacerte G , Labonté M , Brown C , Carpentier AC , Langlois MF , Hivert MF. (2013). Adoption of American Heart Association 2020 Ideal Healthy Diet Recommendations Prevents Weight Gain in Young Adults. Journal of the Academy of Nutrition and Dietetics 113 (11), 1517-22. (Published).
• Shum M , Pinard S , Guimond MO , Labbé SM*, Roberge C , Baillargeon JP , Langlois MF , Alterman M , Wallinder C , Hallberg A , Carpentier AC , Gallo-Payet N. (2013). Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. American Journal of Physiology. Endocrinology and Metabolism 304 (2), E197-210. (Published).
• Poirier P, Dufour R, Carpentier AC, Larose É. (2013). Clinical practice guidelines. Screening for the presence of coronary artery disease. Canadian Journal of Diabetes 37 (37), S105-S109. (Published).
• Bernatchez G , Giroux V , Lassalle T , Carpentier AC , Rivard N , Carrier JC. (2013). ERR? metabolic nuclear receptor controls growth of colon cancer cells. Carcinogenesis 34 (10), 2253-61. (Published).
• Baillargeon JP, St-Cyr-Tribble D, Xhignesse M, Brown C, Carpentier AC, Donovan D, Fortin M, Grant A, Simoneau-Roy J, Langlois MF. (2013). Impact of an integrated obesity care management system on primary care health professionals: a prospective interventional study. Journal of Continuing Education in the Health Professions (Published).
• Borel AL , Boulet G , Nazare JA , Smith J , Alméras N , Tremblay A , Bergeron J , Poirier P , Carpentier AC , Després JP. (2013). Improved Plasma FFA/Insulin Homeostasis Is Independently Associated With Improved Glucose Tolerance After a One-Year Lifestyle Intervention in Viscerally Obese Men. Diabetes Care 36 (10), 3254-61. (Published).
• Allard C , Doyon M , Brown C , Carpentier AC , Langlois MF , Hivert MF*. (2013). Lower leptin levels are associated with higher risk of weight gain over 2 years in healthy young adults. Applied physiology, nutrition, and metabolism = Physiologie appliquée, nutrition et métabolisme 38 (3), 280-5. (Published).
• Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Poirier P, Dufour R, Carpentier A, Larose É. (2013). Screening for the presence of coronary artery disease. Canadian Journal of Diabetes 37 (suppl 1), S105-9. (Published).
• Carpentier AC. (2013). The 2012 CDA-CIHR INMD Young Investigator Award Lecture: Dysfunction of Adipose Tissues and the Mechanisms of Ectopic Fat Deposition in Type 2 Diabetes. Canadian Journal of Diabetes 37 (2), 109-14. (Published).
• Chechi K , Carpentier AC , Richard D. (2013). Understanding the brown adipocyte as a contributor to energy homeostasis. Trends in Endocrinology and Metabolism: TEM 24 (8), 408-20. (Published).
• Gallo-Payet N, Shum M, Baillargeon JP, Langlois MF, Wallinder C, Alterman M, Hallberg A, Carpentier AC. (2012). AT2 receptor agonists: Exploiting the beneficial arm of Ang II signaling. Current Hypertension Reviews 8 (1), 47-59. (Published).
• Trottier A , Battista MC , Geller DH , Moreau B, Carpentier AC , Simoneau-Roy J , Baillargeon JP. (2012). Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Fertility and Sterility 98 (6), 1627-34. (Published).
• Ouellet V*, Labbé SM*, Blondin DP*, Phoenix S, Guérin B , Haman F , Turcotte EE , Richard D, Carpentier AC. (2012). Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. The Journal of Clinical Investigation 122 (2), 545-52. (Published).
• Bessi VL , Labbé SM*, Huynh DN , Ménard L , Jossart C , Febbraio M , Guérin B , Bentourkia M , Lecomte R , Carpentier AC , Ong H , Marleau S. (2012). EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice. Cardiovascular Research 96 (1), 99-108. (Published).
• Carpentier AC , Frisch F , Labbé SM*, Gagnon R , de Wal J , Greentree S , Petry H , Twisk J , Brisson D , Gaudet D. (2012). Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. The Journal of Clinical Endocrinology and Metabolism 97 (5), 1635-44. (Published).
• Sénéchal M , Arguin H , Bouchard DR , Carpentier AC , Ardilouze JL , Dionne IJ , Brochu M. (2012). Effects of rapid or slow weight loss on body composition and metabolic risk factors in obese postmenopausal women. A pilot study. Appetite 58 (3), 831-834. (Published).
• Labbé SM*, Grenier-Larouche T*, Noll C*, Phoenix S , Guérin B , Turcotte EE , Carpentier AC. (2012). Increased myocardial uptake of dietary Fatty acids linked to cardiac dysfunction in glucose-intolerant humans. Diabetes 61 (11), 2701-10. (Published).
• Grenier-Larouche T*, Labbé SM*, Noll C*, Richard D, Carpentier AC. (2012). Metabolic Inflexibility of White and Brown Adipose Tissues in Abnormal Fatty Acid Partitioning of Type 2 Diabetes. Int J Obesity Supplement (2), S37-S. (Published).
• Grenier-Larouche T, Noll C, Labbé SM, Phoenix S, Carpentier AC. (2012). Regulation of nonesterified fatty acid metabolism by sodium 4-Phenybutyrate in a nutritional model of type 2 diabetes. Diabetes (Submitted).
• Arguin H , Dionne IJ , Sénéchal M , Bouchard DR , Carpentier AC , Ardilouze JL , Tremblay A, Leblanc C , Brochu M. (2012). Short- and long-term effects of continuous versus intermittent restrictive diet approaches on body composition and the metabolic profile in overweight and obese postmenopausal women: a pilot study. Menopause (New York, N.Y.) 19 (8), 870-876. (Published).
• Sotornik R , Brassard P , Martin E , Yale P , Carpentier AC , Ardilouze JL. (2012). Update on adipose tissue blood flow regulation. American Journal of Physiology. Endocrinology and Metabolism 302 (10), E1157-70. (Published).
• Carpentier AC, Labbé SM*, Grenier-Larouche T*, Noll C*. (2011). Abnormal fatty acid metabolic partitionning in insulin resistance and type 2. Clinical Lipidology 6 (6), 703-716. (Published).
• Gagnon C*, Brown C , Couture C , Kamga-Ngande CN*, Hivert MF*, Baillargeon JP , Carpentier AC , Langlois MF. (2011). A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes. Diabetes & Metabolism 37 (5), 410-418. (Published).
• Langlois F*, Langlois MF , Carpentier AC , Brown C , Lemieux S , Hivert MF*. (2011). Ghrelin levels are associated with hunger as measured by the Three-Factor Eating Questionnaire in healthy young adults. Physiology & Behavior 104 (3), 373-7. (Published).
• Giacca A , Xiao C , Oprescu AI , Carpentier AC, Lewis GF. (2011). Lipid-induced pancreatic ?-cell dysfunction: focus on in vivo studies. American Journal of Physiology. Endocrinology and Metabolism 300 (2), E255-62. (Published).
• Labbé SM*, Croteau E , Grenier-Larouche T*, Frisch F , Ouellet R , Langlois R , Guérin B , Turcotte EE , Carpentier AC. (2011). Normal postprandial nonesterified fatty acid uptake in muscles despite increased circulating fatty acids in type 2 diabetes. Diabetes 60 (2), 408-15. (Published).
• Labbé SM*, Grenier-Larouche T*, Croteau E , Normand-Lauzière F*, Frisch F , Ouellet R , Guérin B , Turcotte EE , Carpentier AC. (2011). Organ-specific dietary fatty acid uptake in humans using positron emission tomography coupled to computed tomography. American Journal of Physiology. Endocrinology and Metabolism 300 (3), E445-53. (Published).
• Ouellet V*, Routhier-Labadie A*, Bellemare W , Lakhal-Chaieb L , Turcotte E , Carpentier AC , Richard D. (2011). Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. The Journal of Clinical Endocrinology and Metabolism 96 (1), 192-9. (Published).
• Martin E , Brassard P , Gagnon-Auger M , Yale P , Carpentier AC , Ardilouze JL. (2011). Subcutaneous adipose tissue metabolism and pharmacology: a new investigative technique. Canadian Journal of Physiology and Pharmacology 89 (6), 383-91. (Published).
• Sénéchal M , Arguin H , Bouchard DR , Carpentier AC , Ardilouze JL , Dionne IJ , Brochu M. (2011). Weight gain since menopause and its associations with weight loss maintenance in obese postmenopausal women. Clinical Interventions in Aging 6 221-225. (Published).
• Ménard SL*, Croteau E , Sarrhini O , Gélinas R, Brassard P*, Ouellet R , Bentourkia M , van Lier JE , Des Rosiers C , Lecomte R , Carpentier AC. (2010). Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. American Journal of Physiology. Endocrinology and Metabolism 298 (5), E1049-57. (Published).
• Asghari S , Courteau J , Drouin C , Grégoire JP, Carpentier AC , Pâquet M , Vanasse A. (2010). Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysis. Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 7 (2), 167-71. (Published).
• Gagnon C*, Ménard J , Bourbonnais A , Ardilouze JL , Baillargeon JP , Carpentier AC , Langlois MF. (2010). Comparison of foot-to-foot and hand-to-foot bioelectrical impedance methods in a population with a wide range of body mass indices. Metabolic Syndrome and Related Disorders 8 (5), 437-441. (Published).
• Richard D , Carpentier AC , Doré G , Ouellet V*, Picard F. (2010). Determinants of brown adipocyte development and thermogenesis. International Journal of Obesity (2005) 34 (Suppl 2), S59-66. (Published).
• Croteau E , Lavallée E , Labbe SM*, Hubert L , Pifferi F , Rousseau JA , Cunnane SC , Carpentier AC , Lecomte R , Bénard F. (2010). Image-derived input function in dynamic human PET/CT: methodology and validation with 11C-acetate and 18F-fluorothioheptadecanoic acid in muscle and 18F-fluorodeoxyglucose in brain. European Journal of Nuclear Medicine and Molecular Imaging 37 (8), 1539-50. (Published).
• Normand-Lauzière F*, Frisch F , Labbé SM*, Bherer P , Gagnon R , Cunnane SC , Carpentier AC. (2010). Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects. PloS one 5 (6), e10956. (Published).
• Sénéchal M , Arguin H , Bouchard DR , Carpentier AC , Ardilouze JL , Dionne IJ , Brochu M. (2010). Interindividual variations in resting metabolic rate during weight loss in obese postmenopausal women A pilot study. Metabolism: clinical and experimental 59 (4), 478-85. (Published).
• Carpentier AC , Bourbonnais A , Frisch F , Giacca A , Lewis GF. (2010). Plasma nonesterified Fatty Acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. The Journal of Clinical Endocrinology and Metabolism 95 (3), 1256-64. (Published).
• Genest J , McPherson R , Frohlich J , Anderson T , Campbell N , Carpentier AC , Couture P , Dufour R , Fodor G , Francis GA , Grover S , Gupta M , Hegele RA , Lau DC , Leiter L , Lewis GF , Lonn E , M. (2009). 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. The Canadian journal of cardiology 25 (10:567-79), (Published).
• Kamga-Ngandé CN*, Carpentier AC , Nadeau-Marcotte F , Ardilouze JL , Baillargeon JP , Bellabarba D , Houde G , Langlois MF. (2009). Effectiveness of a multidisciplinary program for management of obesity: the Unité d'Enseignement, de Traitement et de Recherche sur l'Obésité (UETRO) database study. Metabolic syndrome and related disorders 7 (4), 297-304. (Published).
• Ménard SL , Ci X , Frisch F , Normand-Lauzière F , Cadorette J , Ouellet R , Van Lier JE , Bénard F , Bentourkia M , Lecomte R , Carpentier AC. (2009). Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 11 ((1):6-14), (Published).
• Asghari S , Courteau J , Carpentier AC , Vanasse A. (2009). Optimal strategy to identify incidence of diagnostic of diabetes using administrative data. BMC medical research methodology 9 (62), (Published).
• Lavoie F , Frisch F , Brassard P , Normand-Lauzière F , Cyr D , Gagnon R , Drouin R , Baillargeon JP , Carpentier AC. (2009). Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. The Journal of clinical endocrinology and metabolism 94 (3), 998-1004. (Published).
• Beriault K , Carpentier AC , Gagnon C , Ménard J , Baillargeon JP , Ardilouze JL , Langlois MF. (2009). Reproducibility of the 6-minute walk test in obese adults. International journal of sports medicine 30 (10), 725-727. (Published).
• Vanasse A , Carpentier AC , Courteau J , Asghari S. (2009). Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients. Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 6 (2:87-93), (Published).
• Baillargeon JP, Carpentier AC. (2008). Correlates between hyperinsulinism and hyperandrogenemia?. Fertil Steril. 89 (4), 1034. (Published).
• Arguin H , Bouchard DR , Labonté M , Carpentier AC , Ardilouze JL , Dionne IJ , Brochu M. (2008). Correlation between the rate of weight loss and changes in body composition in obese postmenopausal women after 5 weeks: a pilot study. Applied physiology, nutrition, and metabolism = Physiologie appliquée, nutrition et métabolisme 33 (2:347-55), (Published).
• Brassard P , Frisch F , Lavoie F , Cyr D , Bourbonnais A , Cunnane SC , Patterson BW , Drouin R , Baillargeon JP , Carpentier AC. (2008). Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes. The Journal of clinical endocrinology and metabolism 93 (3:837-44), (Published).
• Carpentier AC. (2008). Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes. Diabetes & metabolism 34 (2:97-107), (Published).
• Roberge C , Carpentier AC , Langlois MF , Baillargeon JP , Ardilouze JL , Maheux P , Gallo-Payet N. (2007). Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. American journal of physiology. Endocrinology and metabolism 293 (6:E1465-78), (Published).
• Baillargeon JP , Carpentier AC. (2007). Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia 50 (12:2424-32), (Published).
• Baillargeon JP , Carpentier A , Donovan D , Fortin M , Grant A , Simoneau-Roy J , St-Cyr-Tribble D , Xhignesse M , Langlois MF. (2007). Integrated obesity care management system -implementation and research protocol. BMC health services research 7 (1:163), (Published).
• Leboeuf R , Perron P , Carpentier AC , Verreault J , Langlois MF. (2007). L-T3 preparation for whole-body scintigraphy: a randomized-controlled trial. Clinical endocrinology 67 (6:839-844), (Published).
• Carpentier AC , Frisch F , Brassard P , Lavoie F , Bourbonnais A , Cyr D , Giguère R , Baillargeon JP. (2007). Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans. American journal of physiology. Endocrinology and metabolism 292 (3:E693-701), (Published).
• Brassard P , Larbi A , Grenier A , Frisch F , Fortin C , Carpentier AC , Fülöp T. (2007). Modulation of T-cell signalling by non-esterified fatty acids. Prostaglandins, leukotrienes, and essential fatty acids 77 (5-6), (337-43). (Published).
• Hivert MF , Langlois MF , Bérard P , Cuerrier JP , Carpentier AC. (2007). Prevention of weight gain in young adults through a seminar-based intervention program. International journal of obesity (2005) 31 (8:1262-9), (Published).
• Baillargeon JP , Carpentier A. (2007). Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertility and sterility 88 (4:886-93), (Published).
• Hivert MF , Langlois MF , Carpentier AC. (2007). The entero-insular axis and adipose tissue-related factors in the prediction of weight gain in humans. International journal of obesity (2005) 31 (5:731-42), (Published).
• Xiao C , Giacca A , Carpentier A , Lewis GF. (2006). Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia 49 (6:1371-9), (Published).
• Turcotte E , Leblanc M , Carpentier A , Bénard F. (2006). Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 8 (6:348-54), (Published).
• Ci X , Frisch F , Lavoie F , Germain P , Lecomte R , van Lier JE , Bénard F , Carpentier AC. (2006). The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 8 (4:237-44), (Published).
• Fulop T , Tessier D , Carpentier A. (2006). The metabolic syndrome. Pathologie-biologie 54 (7:375-86), (Published).
• Larbi A , Grenier A , Frisch F , Douziech N , Fortin C , Carpentier AC , Fülöp T. (2005). Acute in vivo elevation of intravascular triacylglycerol lipolysis impairs peripheral T cell activation in humans. The American journal of clinical nutrition 82 (5:949-56), (Published).
• Carpentier A , Patterson BW , Uffelman KD , Salit I , Lewis GF. (2005). Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals. Atherosclerosis 178 (1:165-72), (Published).
• Carpentier AC , Frisch F , Cyr D , Généreux P , Patterson BW , Giguère R , Baillargeon JP. (2005). On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. American journal of physiology. Endocrinology and metabolism 289 (5:EB849-56), (Published).
• (2004). Les cent tours du tour de taille. Le Médecin du Québec 39:83-89 (39), 83-89. (Published).
• Leung N , Sakaue T , Carpentier A , Uffelman K , Giacca A , Lewis GF. (2004). Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia 47 (2:204-13), (Published).
• Ouzilleau C , Roy MA , Leblanc L , Carpentier A , Maheux P. (2003). An observational study comparing 2-hour 75-g oral glucose tolerance with fasting plasma glucose in pregnant women: both poorly predictive of birth weight. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 168 (4:403-9), (Published).
• Carpentier A , Zinman B , Leung N , Giacca A , Hanley AJ , Harris SB , Hegele RA , Lewis GF. (2003). Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes. Diabetes 52 (6:1485-95), (Published).
• Lam TK , Carpentier A , Lewis GF , van de Werve G , Fantus IG , Giacca A. (2003). Mechanisms of the free fatty acid-induced increase in hepatic glucose production. American journal of physiology. Endocrinology and metabolism 284 (5:E863-73), (Published).
• Carpentier A , Taghibiglou C , Leung N , Szeto L , Van Iderstine SC , Uffelman KD , Buckingham R , Adeli K , Lewis GF. (2002). Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. The Journal of Biological Chemistry 277 (32), 28795-802. (Published).
• Lewis GF , Carpentier A , Adeli K , Giacca A. (2002). Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine reviews 23 (2:201-29), (Published).
• Leung N , Carpentier A, Wang J, Hegele RA , Lewis GF. (2002). Rapid development of massive tendon xanthomas following highly active antiretroviral therapy. Annals of internal medicine 137 (7:624), (Published).
• Carpentier A , Patterson BW , Leung N , Lewis GF. (2002). Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Diabetes 51 (6:1867-75), (Published).
• Carpentier A , Giacca A , Lewis GF. (2001). Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans. Diabetologia 44 (11:1989-97), (Published).
• Carpentier A , Patterson BW , Uffelman KD , Giacca A , Vranic M , Cattral MS , Lewis GF. (2001). The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. Diabetes 50 (6:1402-13), (Published).
• Bigam DL , Pennington JJ , Carpentier A , Wanless IR , Hemming AW , Croxford R , Greig PD , Lilly LB , Heathcote JE , Levy GA , Cattral MS. (2000). Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology (Baltimore, Md.) 32 (1:87-90), (Published).
• Taghibiglou C , Carpentier A , Van Iderstine SC , Chen B , Rudy D , Aiton A , Lewis GF , Adeli K. (2000). Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hams. The Journal of biological chemistry 275 (12:8416-25), (Published).
• Cattral MS , Bigam DL , Hemming AW , Carpentier A , Greig PD , Wright E , Cole E , Donat D , Lewis GF. (2000). Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Annals of surgery 232 (5:688-95), (Published).
• Carpentier A , Mittelman SD , Bergman RN , Giacca A , Lewis GF. (2000). Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49 (3:399-408), (Published).
• Carpentier A , Mittelman SD , Lamarche B , Bergman RN , Giacca A , Lewis GF. (1999). Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. The American Journal of Physiology 276 (6 Pt 1:E), 1055-70. (Published).
• Lemieux S , Patterson BW , Carpentier A , Lewis GF , Steiner G. (1999). A stable isotope method using a [(2)H(5)]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans. Journal of lipid research 40 (11:2111-7), (Published).
• Lewis GF , Carpentier A , Bilinski D , Giacca A , Vranic M. (1999). Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans. The Journal of clinical endocrinology and metabolism 84 (3:1037-46), (Published).
• Lewis GF , Carpentier A , Vranic M , Giacca A. (1999). Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes 48 (3:570-6), (Published).
• Lamarche B , Uffelman KD , Carpentier A , Cohn JS , Steiner G , Barrett PH , Lewis GF. (1999). Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. The Journal of clinical investigation 103 (8:1191-9), (Published).
• Carpentier A , Wither J , Vukusic B , Lawday K , Boss AH , Lewis GF. (1998). An epitaph for sulfated insulin: immunologic profile of the last patients as they are switched from sulfated beef to human insulin. Diabetes care 21 (9:1571-2), (Published).
• Carpentier, A. ; Lewis, G.F. (1998). Diabetes mellitus and dyslipidemia: a rational therapeutic strategy. Canadian Journal of Diabetes Care (22), 28-38. (Published).
• (1998). Pituitary GH-secreting adenoma necrosis during an oral glucose tolerance test in acromegaly. The Endocrinologist (8), 97-99. (Published).
• Carpentier A , Jeannotte S , Verreault J , Lefebvre B , Bisson G , Mongeau CJ , Maheux P. (1998). Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 39 (8), (Published).
• (1998). Severe debilitating xanthomatosis in a French Canadian patient with heterozygous familial hypercholesterolemia. The Endocrinologist 8:373-377, 1998. (8), 373-377. (Published).
• Bellabarba D , Langlois MF , Carpentier A. (1995). [Consensus and controversy on the treatment of differentiated thyroid cancers]. Annales d'endocrinologie 56 (2:115-8), (Published).
• Asghari S, Orzanco MG, Cohen A, Courteau J, Drouin C, Pâquet M, Carpentier AC, Vanasse A. Antidiabetic Medication Use in Rural/Urban Area. Journal of Diabetes (Submitted).
• Kamga C, Carpentier A, Baillargeon JP, Langlois MF. Obesity with metabolic syndrome in clinical practice: improvement in quality of life and cost-effectiveness of an interdisciplinary weight loss program. Int J Obesity (Submitted).
• Hivert MF, Doyon M, Brown C, Carpentier AC, Langlois MF. The insulin resistance is associated with elevated leptin levels in healthy young adults independently of anthropometric measurements, aerobic capacity and lifestyle. Applied Physiology, Nutrition & Metabolism (Revision Requested).

Chapitres de livre

• Neeland IJ, Després JP, Carpentier AC, Poirier P. (2024). Indicators of Central Adiposity A Critical Evaluation of Their Usefulness. George A Bray, Claude Bouchard, John Kirwan, Peter Kartzmarzyk, Leanne Redman, Philip Shauer. Handbook of Obesity (Fifth, 2). United States of America : CRC Press, Tailor & Francis Group. (In Press).

Articles de conférence

• Sanchez-Delgado G, Dumont L, Noll C, Richard G, Frisch F, Fortin M, Phoenix S, Lepage M, Guérin B, Turcotte EE, Blondin DP, Carpentier AC. (2024). A single dose of theB2-adrenergic receptor agonist formoterol does not increase oxidativemetabolism of brown adipose tissue in healthy patients. European Association of the Study of Diabetes conference 2024. (Published).
• Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, Carpentier AC. (2024). Les endocanabinoïdescirculants: des biomarqueurs de la function métabolique des tissus adipeuxblancs chez l’humain?. Réunion Scientifique 2024 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO). (Published).
• Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, Carpentier AC. (2024). in vivoLes endocannabinoïdescirculants sont associés avec la function métabolique des tissus adipeux blancs chez l’humain. Journée. Journée scientifique de la Faculté de médecine et des sciences de la santé de l’Université de Sherbrooke. (Published).
• Fernandez-Fernandez J, Sanchez-Delgado G, Hogan-Lamarre S, Richard G, Frisch F, Phoenix S, Fortin M, Bouffard L, Noll C, Mampuya W, Guérin B, Turcotte EE, Hoeks J, Schrauwen P, Carpentier AC, Blondin DP. (2023). Does myocardium and liverfractional uptake of circulating fatty acids change after consuming a meal inpeople with prediabetes?. European Association of Nuclear Medicine Conference. (Published).
• Noll C, Uy K, Bouyakdan K, Fortin M, Beauchemin S, Phoenix S, Rhéaume E, Alquier T, Tardif JC, Carpentier AC. (2023). L‘expression d’Adcy9 dansles plexus choroïdes ou dans les cellules endothéliales module la thermogénèsedu tissu adipeux brun chez la souris. Réunion Scientifique 2023 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO). (Published).
• Hogan-Lamarre S, Côté M, Lepitre M, Sanchez-Delgado G, Frisch F, Richard G, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin DP. (2023). Postprandial energymetabolism in response to exercise in individuals with prediabetes. Obesity Week 2023. (Published).
• Sanchez-Delgado G, Dumont L, Richard G, Frisch F, Fortin M, Phoenix S, Lepage M, Guérin B, Turcotte EE, Blondin DP, Carpentier AC. (2022). 2022 Diabetes Canada/CSEM Professional Conference. (Published).
• Noll C, Uy K, Bouyakdan K, Fortin M, Beauchemin S, Phoenix S, Rhéaume E, Alquier T, Tardif JC, Carpentier AC. (2022). Adcy9 expression in choroidplexus or endothelial cells modulates brown adipose tissue thermogenesis. Recent Advances & Controversies in the Measurement of Energy Metabolism (RACMEM). (Published).
• Sanchez-Delgado G, Richard G, Hogan-Lamarre S, Ivanova Y, Gendreau M, Frisch F, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin DP. (2022). Effect of exerciseperformed at different times of the day on postprandial metabolism ofindividuals with prediabetes. Danish Diabetes Academy Postdoctoral Summit 2022. (Published).
• Dion D, Noll C, Giguère H, Frégeau G, Sarrhini O, Auger-Messier M, Ong H, Marleau S, Carpentier AC. (2022). Effect of pharmacologicalmodulation of CD36 on total oxidative and nonesterified fatty acid metabolismin a nutritional model of insulin resistance. Recent Advances & Controversies in the Measurement of Energy Metabolism (RACMEM). (Published).
• Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, Carpentier AC. (2022). Les endocanabinoïdes circulants: des biomarqueurs de la function métabolique des tissus adipeuxblancs chez l’humain?. 2022 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress. (Published).
• Ye RZ*, Montastier E*, Frisch, F, Noll C, Gévry N, Allard-Chamard H, Tchernof A, Carpentier A. (2022). Single Nuclei RNA-Sequencing of Frozen Human Adipose Tissue and PET/CTImaging Coupled With Deep-Learning Reveals Single-Cell Landscape andTranscriptional Dynamics Related to Adipocyte Hypertrophy and in VivoDysmetabolism (OR23). ENDO 2022. (Published).
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2021). L’augmentation du fluxpostprandial d’acide gras non-estérifié chez les sujets pré-diabétiques estmodérée par une amélioration du captage d’AG dans les tissus adipeux. ACFAS Congress. (2021). (Published).
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2021). L’implication del’hypertrophie adipocytaire dans le métabolisme lipidique systémique in vivochez l’humain. Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (Published).
• Ye RZ*, Phoenix S, Amrani M, Bouffard L, Frisch F, Turcotte EE, Montastier E*, Noll C, Carpentier AC. (2020). 1866-P | Adipocyte Hypertrophy Is Associated withIncreased Dietary Fatty Acid Storage in Adipose Tissue and Reduced PostprandialHepatic Fatty Acid Uptake and Esterification in Humans. American Diabetes Association Virtual 80th Scientific Sessions. (Published).
• Dion D, Noll C, Giguère H, Frégeau G, Sarrhini O, Auger-Messier M, Ong H, Marleau S, Carpentier AC. (2020). Effet de la modulation deCD36 sur le métabolisme oxydatif et des acides gras non-estérifiés dans unmodèle nutritionnel de résistance à l’insuline. 2020 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress. (Published).
• Montastier E, Noll C, Ye RZ, Amrani M, Frisch F, Fortin M, Bouffard L, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Carpentier AC. (2020). Effet de l’inhibition pharmacologique de la lipolyse adipocytaire sur le métabolisme post-prandial des acides gras alimentaires. 2020 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress. (Published).
• Richard G, Noll C, Archambault M, Lebel R, Tremblay L, Ait-Mohand S, Carpentier AC, Lepage M. (2020). Estimation of brown adiposetissue perfusion by DCE-MRI improves measurement of oxidative metabolism by11C-acetate PET in a rat model. ISMRM Annual Meeting. (Published).
• Richard G, Blondin DP, Frisch F, Fortin M, Thibodeau C, Dubreuil S, Noll C, Lepage M, Carpentier AC. (2020). Organ-specific metabolicchanges induced by a high fructose diet. Imagining Imaging Symposium. (Published).
• Montastier E*, Noll C, Ye RZ*, Amrani M, Frisch F, Fortin M, Bouffard L, Sarrhini O, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Carpentier AC. (2020). The Effect of Inhibition of Fatty Acid Spillover from Adipose Tissues onOrgan-Specific Distribution of Dietary Fatty Acids. American Diabetes Association Virtual 80th Scientific Sessions. (Published).
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2020). The implication of humanadipocyte hypertrophy in in vivo systemic lipid metabolism and insulinresistance. 2020 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress. (Published).
• Richard G, Blondin DP, Noll C, Lebel R, Lepage M, Carpentier AC. (2019). Advanced 11C-acetatekinetic modeling for brown adipose tissue assessment”. Saltin InternationalCourse in Exercise and Clinical Physiology. Saltin International Course in Exercise and Clinical Physiology. (Published).
• Dion D, Noll C, Giguère H, Frégeau G, Sarrhini O, Auger-Messier M, Ong H, Marleau S, Carpentier AC. (2019). Effet de la modulation deCD36 sur le métabolisme oxydatif et des acides gras non-estérifiés dans unmodèle nutritionnel de résistance à l’insuline. Journée scientifique de la Faculté de médecine et des sciences de la santé de l’Université de Sherbrooke. (Published).
• Turcotte AF, Grenier-Larouche T*, Carreau AM*, Carpentier AC, Mac-Way F, Tchernof A, Richard D, Biertho L, Lebel S, Marceau S, Ferron M, Gagnon C. (2019). Improvement in Glucose Homeostasis After Biliopancreatic Diversion isAssociated with Increased Uncarboxylated Osteocalcin. 24th World Congress of International Federation for the Surgery of Obesity. (Published).
• Richard G, Blondin DP, Noll C, Lebel R , Lepage M , Carpentier AC. (2019). Kinetic modeling of11C-acetate in brown adipose tissue. RBIQ. (Published).
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2019). The implication of humanadipocyte hypertrophy in in vivo systemic lipid metabolism and insulinresistance. Journée Phare 2019, congrès québécois en sciences de la santé (Quebec congress in health sciences). (Published).
• Carreau AM*, Noll C, Guérin B, Biertho L, Turcotte EE, Tchernof A, Carpentier AC. (2018). Early effects of sleeve gastrectomy (SC) on systemic and organ-specific dietary fatty acid uptake, postprandial free fatty acids (FFA), and glucose metabolism in type 2 diabetes (T2D). American Diabetes Association's 78th Scientific Sessions. DOI. (Published).
• Turcotte AF, Grenier-Larouche T* Ung RV, Carreau AM*, Carpentier AC, Mac-Way F, Gagnon C. (2018). Effects of biliopancreaticdivision on bone turnover markers and association with hormonal factors inpatients with severe obesity. 2nd Canadian Musculoskeletal Conference. (Published).
• Turcotte AF, Grenier-Larouche T*, Ung RV, Carreau AM*, Carpentier AC, Mac-Way F, Gagnon C. (2018). Effects of biliopancreatic division on bone turnover markers and association with hormonal factors inpatients with severe obesity. Journée de la recherché en santé de l’Université de Laval. (Published).
• Carreau AM*, Nadeau M, Noll C, Frisch F, Bouffard L, Phoenix S, Guérin B, Biertho L, Tchernof A, Carpentier AC. (2017). Effets précoces de la gastrectomie pariétale (GP) sur la métabolisme prostprandial des lipides alimentaires. 6e Journée scientifique de l’Axe/Thème/Centre d’excellence de l’Université de Sherbrooke en Diabète, Obésité et complications cardiovasculaires (DOCC). (Published).
• Grenier-Larouche T*, White PJ, Biertho L, Kwee L, Shah S, Carpentier AC, Newgard CB, Tchernof A. (2017). Interaction entre le métabolisme des lipides et des acides aminés dans le développement de la maladie hépatique non alcoolique. Réunion scientifique annuelle 2017 de la SQLNM, du Réseau CMDO et du Congrès COLosSUS. (Published).
• Chénard T*, Carpentier AC, Tchernof A, Najmanovich R. (2017). Modulation du métabolisme de l’adipocyte pour prévenir le diabète de type 2 : une analyse in silico du réseau iTC1390adip. Réunion scientifique annuelle 2017 de la SQLNM, du Réseau CMDO et du Congrès COLosSUS. (Published).
• Noll C, Kunach M*, Frisch F, Bouffard L, Dubreuil S, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Laville M, Carpentier AC. (2017). Une surnutrition de 7 jours diminue la répartition des acides gras postprandiaux au niveau du myocarde chez des sujets en santé. Réunion scientifique annuelle 2017 de la SQLNM, du Réseau CMDO et du Congrès COLosSUS. (Published).
• Chénard T*, Carpentier AC, Tchernof A, Najmanovich R. (2017). Validation expérimentale de gènes prédits comme affectant le métabolisme des adipocytes dans le diabète de type 2. 6e Journée scientifique de l’Axe/Thème/Centre d’excellence de l’Université de Sherbrooke en Diabète, Obésité et complications cardiovasculaires (DOCC). (Published).
• Noll C, Auger-Messier M, Geraldes P, Baillargeon JP, Dumaine R, Leduc R, Benrezzak O, Carpentier AC. (2016). Analyse du transcriptome et de la dépense énergétique quotidienne dans un modèle de rat de résistance à l’insuline. 5e Journée scientifique Axe/Thème et Centre d’excellence de l’Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC). (Published).
• Blondin DP*, Labbé SM, Phoenix S, Guérin B, Turcotte EE, Richard D, Carpentier AC. (2016). Contributions of white and brown adipose tissues and skeletal muscles to cold-induced metabolic responses. Obesity Week 2016. (Published).
• Noll C, Kunach M, Frisch F, Bouffard L, Dubreuil S, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. (2016). Effet d’une surnutrition de 7 jours sur le métabolisme postprandial des acides gras alimentaires chez des sujets en santé. Réunion annuelle SQLNM/ CMDO/ COLosSUS. (Published).
• Carreau AM, Noll C, Nadeau M, Biertho L, Richard D, Tchernof A, Carpentier AC. (2016). Effets précoces de la gastrectomie pariétale(GP) et de la dérivation biliopancréatique avec commutation duodénale (DBP-CD) sur le métabolisme postprandial des lipides. Réunion annuelle SQLNM/ CMDO/ COLosSUS. (Published).
• Blondin D, Phoenix S, Guérin B, Turcotte EE, Haman F, Carpentier A. (2016). Le rôle des triglycérides intracellulaires sur le métabolisme de la graisse brune chez des hommes sains exposés au froid. Réunion annuelle SQLNM/ CMDO/ COLosSUS. (Published).
• Chénard T*, Carpentier AC,Tchernof A, Najmanovich R. (2016). L’utilisation d’un réseau métabolique d’adipocyte dans l’étude de mécanismes menant au développement du diabète de type 2. 5e Journée scientifique Axe/Thème et Centre d’excellence de l’Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC). (Published).
• Chénard T*, Carpentier AC, Tchernof A, Najamanovich R. (2016). L’utilisation d’un réseau métabolique d’adipocytes humains dans l’étude du métabolisme des lipides dans le contexte du développement du diabète de type 2. Réunion annuelle SQLNM/ CMDO/ COLosSUS. (Published).
• Grenier-Larouche T*,Careau AM*, Frisch, F,Biertho L, Marceau S, Lebel S, Hould FS, Richard D, Tchernof A, Carpentier AC. (2016). Modifications du métabolisme du glycérol et des acides gras non-estérifiés comme vecteur de rémission du diabète de type 2 en réponse à la chirurgie bariatrique. 5e Journée scientifique Axe/Thème et Centre d’excellence de l’Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC). (Published).
• Faubert J, Baptiste G. C, Naimi F, Bellanger S, Gallo-Payet N, Battista MC, Benrezzak O, Carpentier AC, Baillargeon JP. (2016). Une surexposition aux acides gras non estérifiés in vivo augmente les niveaux d’androgènes circulant dans un modèle de chiens normaux. 5e Journée scientifique Axe/Thème et Centre d’excellence de l’Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC). (Published).
• Carreau A-M, Grenier-Larouche T, Biertho L, Tchernof A, Carpentier AC. (2015). Effect of Insulin-Resistance, Diabetes and Biliopancreatic Diversion with Duodenal Switch (BDP-DS) on Acylcarnitines (AC) under Fasting, Postprandial, Hyperinsulinemic and Hyperlipidemic Conditions In Severely Obese Patients. 2015 Professional Conference and 18th Annual Meeting of the CSEM. (Published).
• Stroes ES, Bernelot-Moens SJ, Carpentier AC, Frish F, Petry H, Meyer C, Brisson D, Bruno M, Gaudet D. (2015). Gene Therapy for Lipoprotein Lipase Deficiency (LPLD): Learnings From the Clinical Development of Alipogen tiparvovec, an AAV1 therapy for LPLD. 17th Triennial Congress of the International Atherosclerosis Society, ISA 2015. (Accepted).
• Grenier-Larouche T, Frisch F, Caron-Dorval C, Biron S, Hould F, Biertho L, Richard D, Tchernof A, Carpentier A. (2015). Impaired nonesterified fatty acid (NEFA) metabolism in type 2 diabetes (T2D) is rapidly corrected after biliopancreatic diversion with duodenal switch (BPD/DS). 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases. (Published).
• Blondin DP, Haman F, Richard D, Carpentier AC, Guérin B, Phoenix S, Turcotte E. (2015). Inhibition of intracellular triglyceride lipolysis significantly impairsBAT oxidative metabolism in humans (oral presentation). 2016 Keystone Symposia Conference. (Accepted).
• Chénard T, Carpentier A, Tchernof A, Najmanovich R. (2015). Lipid metabolism and storage in adipocytes studied via metabolic network linked to the development of type two diabetes. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases. (Published).
• Blondin DP, Noll C, Tingelstad H, Labbé SM, Guérin B, Turcotte EE, Richard D, Haman F, Carpentier, AC. (2015). Postprandial energy metabolism of brown adipose tissue in cold-acclimated humans. Keystone Symposia, 'Beige and Brown Fat: Basic Biology and Novel Therapeutics. (Accepted).
• Noll C, Kunach M, Frisch F, Bouffard L, Dubreuil S, Jean-Denis F, Phoenix S, Guérin B, Turcotte E, Carpentier AC. (2015). Seven-day caloric and saturated fat restriction increases myocardial dietary fatty acid partitioning in impaired glucose-tolerant subjects. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases. (Accepted).
• Noll C, Kunach M, Frisch F, Bouffard L, Dubreuil S, Jean-Denis F, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. (2015). Un régime hypocalorique et pauvre en acides gras saturés induit une augmentation du captage des acides gras chez des sujets intolérants au glucose en période postprandiale. 4e Journée scientifique du DOCC. (Published).
• Kunach M, Noll C, Phoenix S, Guérin B, Baillargeon JP, Turcotte E, Carpentier AC. (2014). Effect of Gender and Impaired Glucose Tolerance on Postprandial Dietary Fatty Acid Metabolism and Myocardial Function in Humans. 74th Scientific Sessions of the American Diabetes Association. (Published).
• Kunach M, Noll C, Phoenix S, Guérin B, Baillargeon JP, Turcotte É, Carpentier AC. (2014). Effets du sexe et de l'intolérance au glucose sur le métabolisme des acides gras alimentaires et la fonction cardiaque en période postprandiale chez l'humain. 3e Journée scientifique du DOCC. (Published).
• Kunach M, Noll C, Phoenix S, Guérin B, Baillargeon JP, Turcotte E, Carpentier AC. (2014). Effets du sexe et de l’intolérance au glucose sur le métabolisme des acides gras alimentaires et la fonction cardiaque en période postprandiale chez l’humain. Congrès SQLNM/ CMDO/ COLosSUS 2014. (Published).
• Noll N, Kunach M, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2014). Hepatic metabolism of dietary fatty acids (DFA) in subject with impaired glucose tolerance during postprandial state after a 7-days hypocaloric diet low in saturated fat. 74th Scientific Sessions of the American Diabetes Association. (Published).
• Grenier-Larouche T, Frisch F, Caron-Dorval D, Biron S, Marceau S, Hould F, Lebel S, Biertho L, Tchernof A, Richard D, Carpentier AC. (2014). La diminution des flux d’acides gras plasmatiques participe à l’amélioration du métabolisme du glucose suite à la dérivation biliopancréatique avec commutation duodénale. Congrès SQLNM/ CMDO/ COLosSUS 2014. (Published).
• Chénard T, Carpentier AC, Tchernof A, Najmanovich R. (2014). L’utilisation de la biologie des systèmes dans l’étude du métabolisme des lipides en lien avec le développement du diabète de type 2. 3e Journée scientifique du DOCC. (Published).
• Grenier-Larouche T, Frisch F, Caron-Dorval D, Biron S, Marceau S, Hould FS, Lebel S, Biertho L, Tchernof A, Richard D, Carpentier AC. (2014). Résolution à court terme de l’intolérance aux lipides suite à la dérivation biliopancréatique avec commutation duodénale (DBP-CD). 3e Journée scientifique du DOCC. (Published).
• Noll C, Kunach M, Frisch F, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2014). Un régime hypocalorique et pauvre en acides gras saturés induit une augmentation du captage des acides gras chez des sujets intolérants au glucose en période postprandiale. Congrès SQLNM/ CMDO/ COLosSUS 2014. (Published).
• Noll C, Kunach M, Frisch F, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2014). Un régime hypocalorique et pauvre en acides gras saturés induit une augmentation du captage myocardial des acides gras chez des sujets intolérants au glucose en période postprandiale. 3e Journée scientifique du DOCC. (Published).
• Chénard T, Carpentier AC, Tchernof A, Najmanovich R. (2014). Utilisation de la biologie des systèmes dans l?étude du métabolisme des lipides en lien avec le développement du diabète de type 2. Congrès SQLNM/ CMDO/ COLosSUS 2014. (Published).
• Boutin M, Fortin M, Frisch F, Carpentier AC, Auray-Blais C. (2013). 13C16-Palmitic Acid Metabolization into Ceramide for the Determination of Ceramide Synthesis in Type 2 Diabetes Patients. 9th Annual Conference of the Metabolomics Society. (Published).
• Plourde CE, Grenier Larouche T, Caron-Dorval D, Biron S, Lebel S, Tchernof A, Richard D, Carpentier AC. (2013). Biliopancreatic Diversion-induced Rapid Reversal of Beta Cell Dysfunction in Type 2 Diabetes is associated with Caloric Restriction, not improved Incretin Secretion. 73rd ADA Scientific Sessions. (Published).
• Gagnon C, Daly RM, Carpentier AC, Lu ZX, Shore-Lorenti C, Sikaris K, Jean S, Ebeling PR. (2013). Effect of Combined Calcium and Vitamin D Supplementation on Insulin Secretion and Insulin Sensitivity in Vitamin D-deficient Adults at High Risk of Type 2 Diabetes. ASBMR 2013 Annual Meeting. (Published).
• Dutia R, Brakoniecki K, McGinty J, Ren-Fielding C, Homel P, Rosen D, Koshy N, Harvey EJ, Carpentier AC, Laferrère B. (2013). Effects of Roux-en-Y gastric bypass versus gastric banding on ?-cell function in patients with diabetes after ~10% and ~25% weight loss. The Obesity Society Annual Meeting. (Published).
• Kunach M, Noll C, Labbé SM, Grenier-Larouche T, Bouffard L, Phoenix S, Guérin B, Baillargeon JP, Langlois MF, Turcotte EE, Carpentier AC. (2013). Effets des habitudes de vie sur les anomalies du métabolisme postprandial des acides gras alimentaires chez les patients intolérants au glucose. 42e Journée scientifique FMSS, Université de Sherbrooke. (Published).
• Kunach M, Noll C, Labbé SM, Grenier-Larouche T, Bouffard L, Phoenix S, Guérin B, Baillargeon JP, Langlois MF, Turcotte EE, Carpentier AC. (2013). Effets des habitudes de vie sur les anomalies du métabolisme postprandial des acides gras alimentaires chez les patients intolérants au glucose. 2e Journée scientifique annuelle du Thème/Axe DOCC. (Published).
• Leblanc S, Noll C, Battista MC, Gallo-Payet N, Vine DF, Carpentier AC, Baillargeon JP. (2013). Implication des acides gras non-estérifiés dans l’hyperandrogénie d’un modèle de rat du syndrome des ovaires polykystiques. 2e Journée scientifique annuelle du Thème/Axe DOCC. (Published).
• Kunach M, Noll C, Labbé SM, Grenier-Larouche T, Bouffard L, Phoenix S, Guérin B, Baillargeon JP, Langlois MF, Turcotte EE, Carpentier AC. (2013). Improved Cardiopulmonary Functional Capacity Following a One-Year Lifestyle Intervention Regimen Does Not Explain Improved Postprandial Myocardial Dietary Fatty Acid Metabolism in Patients with Impaired Glucose Tolerance. CDA/CSEM Professional Conference & Annual Meetings. (Published).
• Veilleux A, Grenier É, Marceau P, Carpentier AC, Richard , Levy É. (2013). Inflammation and oxidative stress in the small intestine are associated with insulin resistance and alterations in lipid homeostasis in obese subjects. Digestive Disease Week 2013. (Published).
• Blondin DP, Labbé SM, Turcotte EE, Richard D, Carpentier AC, Haman F. (2013). La contribution thermogénique du tissu adipeux brun augmente suite è un protocole d’acclimatation au froid chez des hommes sains. 5e Réunion annuelle COLosSUS. (Published).
• Labbé SM, Baraboi ED, Grenier-Larouche T, Roy MC, Noll C, Li W, Bouchard C, Lecomte R, Carpentier AC, Richard D. (2013). La perte de poids associée è la chirurgie bariatrique n’est pas due à une augmentation de la capacité et du metabolisme du tissu adipeux brun chez le rat. 5e Réunion annuelle COLosSUS. (Published).
• Bouchouirab FZ, Fortin M, Dubé J, Carpentier AC. (2013). Le débordement des aclcarnitines dans la circulation n’est pas établi chez les sujets à haut risque de développer un diabète de type 2, mais confirmé chez les diabétiques type 2. 2e Journée scientifique annuelle du Thème/Axe DOCC. (Published).
• Labbé SM, Blondin DP, Noll C, Kunach M, Guérin B. Turcotte EE, Haman F, Carpentier AC, Richard D. (2013). L’exposition aigue au froid n’induit pas l’activation du tissu adipeux brun chez le patient diabétique. 5e Réunion annuelle COLosSUS. (Published).
• Chénard T, Carpentier AC, Najmanovich R. (2013). L’utilisation de la biologie des systèmes dans l’analyse du métabolisme des lipides en lien avec le développement du diabèete de type 2. 2e Journée scientifique annuelle du Thème/Axe DOCC. (Published).
• Plourde CE, Caron-Dorval D, Grenier-Larouche T, Biron S. Richard D, Carpentier AC. (2013). Mécanismes de résolutions précoces du diabète de type 2 (DT2) suivant la dérivation biliopancréatique avec commutation duodénale (DPB/CD). 5e Réunion annuelle COLosSUS. (Published).
• Noll C, Labbé SM, Kunach M, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2013). Métabolisme postprandial des acides gras alimentaires chez des sujets intolérants au glucose lors d’un régime hypocalorique et pauvre en acides gras saturés. 5e Réunion annuelle COLosSUS. (Published).
• Leblanc S, Noll C, Battista MC, Vine DF, Gallo-Payet N, Carpentier AC, Baillargeon JP. (2013). Role of Non-Esterified Fatty Acid in the Hyperandrogenemia of a Rat Model of Polycystic Ovary Syndrome. Endo 2013. (Published).
• Grenier-Larouche T, Galinier A, Casteilla L, Michaud A, Carpentier AC, Tchernof A. (2013). Réduction du contenu en coenzyme Q10 et modification du statut redox dans l’obésité et l’hypertrophie adipocytaires des tissus adipeux humains. Congrès SQLNM/CMDO 2013. (Published).
• Leblanc S, Noll C, Battista MC, Gallo-Payet N, Vine DF, Carpentier AC, Baillargeon JP. (2013). Rôle des acides gras non-estérifies dans l'hyperandrogenie d'un modèle de rat du syndrome des ovaires polykystiques. 55e Réunion annuelle du CRCQ. (Published).
• Leblanc S, Noll C, Battista MC, Gallo-Payet N, Vine DF, Carpentier AC, Baillargeon JP. (2013). Rôle des acides gras non-estérifiés dans l’hyperandrogénie d’un modèle de rat du syndrome des ovaires ploykystiques. Congrès SQLNM-CMDO 2013. (Published).
• Leblanc S, Battista MC, Gallo-Payet N, Vine D, Noll C, Carpentier AC, Baillargeon JP. (2013). Rôle des acides gras non-estérifiés dans l’hyperandrogénie d’un modèle de rat du syndrome des ovaires polykystiques. 5e Réunion annuelle COLosSUS. (Published).
• Labbe SM, Carpentier AC, Richard D, Lecomte R. (2013). SNS-mediated activation of brown adipose tissue capacity and metabolism. Keystone Symposia Neuronal Control of Appetite, Metabolism and Weight (C6). (Published).
• Labbe SM, Baraboi ED, Grenier-Larouche T, Roy MC, Noll C, Li W, Bouchard C, Lecomte R, Carpentier AC, Richard D. (2013). Weight Loss Associated to Bariatric Surgery Was Not Coupled to an Enhanced Activity of Brown Adipose Tissue Capacity and Metabolism in Rodents. 73rd ADA Scientific Sessions. (Published).
• Lachance D, Vaillant F, Daneault C, Frayne-Robillard I, Duval F, Deschepper C, Carpentier AC, Tardif JC, Des Rosiers C. (2012). A high fat/high fructose (HF) diet does not exacerbate metabolic or cardiac functional alterations induced by diabetes in mice. 2012 Experimental Biology. (Published).
• Plourde CE, Caron-Dorval D, Grenier Larouche T, Biron S, Richard D, Carpentier AC. (2012). Characterisation of glucose homeostasis and caloric restriction early after biliopancreatic diversion with duodenal switch (BPD/DS). 2012 CDA/CSEM Annual Congress. (Published).
• Labbé SM, Grenier?Larouche T, Baraboï ED, Noll C, Bouchard C, Shooner J, Carpentier AC, Richard D. (2012). Détermination du partionnement des gras alimentaires suite à une dérivation bilio-pancréatique (DBP) chez le rat. 4e Réunion annuelle de la plate-forme COLosSUS. (Published).
• Twisk J, Frisch F, Sier-Ferreira V, van den Bulk N, Petry H, Carpentier AC, Gaudet D. (2012). Long-term transgene expression and biological activity following IM administration of AAV1-LPLS447X to LPL deficient patients. ASGCT 2012 15th Meeting. (Published).
• Plourde CE, Caron?Dorval D, Biron S, Marceau S, Lebel S, Laroche S, Carpentier AC, Richard D. (2012). L’évolution temporelle de l’homéostasie du glucose ainsi que la restriction calorique sévère suivant la dérivation biliopancréatique avec commutation duodénale. 4e Réunion annuelle de la plate-forme COLosSUS. (Published).
• Johnson-Black P, Bunker P, Embrey M, Paultre F, Carpentier AC, Laferrere B. (2012). Normalization of beta cell glucose sensitivity after gastric bypass in patients with type 2 diabetes (DM). 72nd Scientific Sessions American Diabetes Association. (Published).
• Veilleux A, Grenier E, Carpentier AC, Richard D, Lévy E. (2012). Perturbation du métabolisme lipidique dans l’intestin de patients obèses et insulino-résistants. 13e Réunion annuelle de la SQLNM. (Published).
• Bilodeau S, Hivert MF, Xhignesse M, Brown C, Carpentier AC, Langlois MF. (2012). Peut-on augmenter la compétence des médecins dans le soutien au changement des habitudes de vie ?. 4e Réunion annuelle de la plateforme COLosSUS. (Published).
• Lacerte G, Lacroix M, Doyon M, Brown C, Carpentier AC, Langlois MF, Hivert MF. (2012). Physiopathologie du gain de poids chez les jeunes adultes : lien entre le gain de poids, les changements de sensibilité à l’insuline et les niveaux sanguins d’adiponectine. 13e Réunion annuelle de la SQLNM. (Published).
• Lacerte G, Lacroix M, Doyon M, Brown C, Carpentier AC, Langlois MF, Hivert MF. (2012). Physiopathologie du gain de poids chez les jeunes adultes : liens entre le gain de poids, les changements de sensibilité à l’insuline et les niveaux circulants d’adiponectine. 1re Journée scientifique de l’Axe/Thème Diabète, Obésité et Complications Cardiovasculaires. (Published).
• Bunker P, Johnson-Black P, Carpentier AC, Wang G, Agenor K, Paultre P, Embrey M, Obrien C, ColarussoA, Laferrère B. (2012). Prehepatic insulin secretion rate 3 years after GBP in patients with T2DM. 30th Annual Scientific Meeting Obesity Society 2012. (Published).
• Plourde CE, Caron-Dorval D, Biron S, Richard D, Carpentier AC. (2012). Rapid improvement of triglyceride but not nonesterified fatty acid metabolism may contribute to rapid improvement of glucose homeostasis after biliopancreatic diversion with duodenal switch (BPD/DS). XVII World Congress IFSO 2012. (Published).
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2012). Redistribution des flux d’acides gras suite à un traitement au 4?phénylbutyrate dans un modèle nutritionnel de diabète de type 2. 4e Réunion annuelle de la plate-forme COLosSUS. (Published).
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2012). Regulation of nonesterified fatty acid metabolism by sodium 4-phenybutyrate in a nutritional model of type 2 diabetes. 2012 CDA/CSEM Annual Congress. (Published).
• Forget G, Doyon M, Lacerte G, Labonté M, Brown C, Carpentier AC, Langlois MF, Hivert MF. (2012). Très faible prévalence d’une alimentation idéale et d’une santé cardiovasculaire idéale telles que définies par l’American Heart Association chez les jeunes adultes. 1re Journée scientifique de l’Axe/Thème Diabète, Obésité et Complications Cardiovasculaires. (Published).
• Caron-Dorval D, Plourde CÉ, Biron S, Marceau S, Biertho L, Richard D, Carpentier AC. (2012). Évolution de l’homéostasie du glucose et restriction calorique sévère suivant la chirurgie bariatrique par DBP/CD. 13e Réunion annuelle de la SQLNM. (Published).
• Grenier-Larouche T, Labbé SM, Rivard N, Carpentier AC. (2011). 4-Phenylbutyrate reverses endoplasmic reticulum stress and lipotoxicity in human adipose tissue stem cells. 2nd National Obesity Summit, Published in Canadian Journal of Diabetes 35 (2): 139. (Published).
• Twisk J, Greentree S, de Wal J, Gagné C, Carpentier AC, Gaudet D, van den Bulk N, Freidig A. (2011). Alipogene tiparvovec gene therapy enhances post-prandial clearance of chylomicrons in lipoprotein lipase deficient patients. 79th European Atherosclerosis Society Congress. (Published).
• Shum M, Labbé SM, Carpentier AC, Gallo-Payet N. (2011). Angiotensin Type 2 Receptor (AT2R) activation prevent insulin resistance by modulating adipocyte physiology. Canadian Diabetes Association. (Published).
• Bessi VL, Labbé SM, Huynh DN, Carpentier AC, Marleau S, Ong H. (2011). Cardioprotective effects of CD36 ligands following transient ischemia-reperfusion in the mouse. Keystone Symposia ''Lipid Biology and Lipotoxicity''. (Published).
• Plourde CÉ, Carpentier AC. (2011). Characterization of Glucose Homeostasis and Caloric Restriction Early after Biliopancreatic Diversion with Duodenal Switch. Canadian Diabetes Association. (Published).
• Labbé SM, Ouellet V, Blondin DP, Haman F, Turcotte EE, Richard D, Carpentier AC. (2011). Cold induced thermogenesis in brown adipose tissue in humans. Canadian Diabetes Association. (Published).
• Trottier A, Battista MC, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Early metabolic and endocrine perturbations in first degree relative adolescent girls of polycystic ovary syndrome women. 93rd Annual Meeting of the Endocrine Society. (Published).
• Trottier A, Battista MC, Carpentier AC, Simoneau-Roy J, Geller D, Baillargeon JP. (2011). Early metabolic and endocrine perturbations in pre-or peripubertal girls with a first degree relative with polycystic ovary syndrome. American Society for Reproductive Medicine 67th Annual Meeting. (Published).
• Trottier A, Battista MC, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Early metabolic and endocrine perturbations in pre- or peripubertal girls with a first degree relative with polycystic ovary syndrome. Androgen Excess & PCOS Society 9th Annual Meeting. (Published).
• Labbé SM, Noll C, Grenier-Larouche T, Lavallée E, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. (2011). Effect of weight loss on organ-specific dietary fatty acid uptake in impaired glucose tolerance. Canadian Diabetes Association. (Published).
• Grenier-Larouche T, Labbé SM, Rivard N, Carpentier AC. (2011). Effet des chaperons chimiques sur le stress du réticulum endoplasmique et la biologie de l’adipocyte. 3e Réunion annuelle de la plateforme COLosSUS. (Published).
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2011). Effet du 4-Phenylbutyrate dans un modèle nutritionnel de diabète de type 2. 13e Journée scientifique de l'Axe des maladies endocriniennes et métaboliques du Centre de recherche clinique Étienne-Le Bel. (Published).
• Labbé SM, Bilodeau L, Gallo-Payet N, Carpentier AC. (2011). Glucose and fatty acid heart and brain uptake in WT and AT2 receptor-deficient mice. 37e Colloque de la Société de Neuroendocrinologie et 4e Colloque franco-québécois. (Published).
• Labbé SM, Grenier-Larouche T, Lavallée E, Lessard D, Thibodeau C, Phoenix S, Guerin B, Turcotte EE, Carpentier AC. (2011). Impact des acides gras alimentaires (AGA) dans le développement de la lipotoxicité chez des sujets intolérants au glucose (IG+). 3e Réunion annuelle de la plateforme COLosSUS. (Published).
• Twisk J, Frisch F, Greentree S, Petry H, de Wal J, Brisson D, Gagné C, Carpentier AC, Gaudet D. (2011). Improved chylomicron clearance as a marker for long-term efficacy of alipogene tiparvovec (AAV1-LPLS447X gene therapy) in LPLD patients. American Society of Gene & Cell Therapy 14th Annual Meeting. (Published).
• Bilodeau S, Hivert MF, Xhignesse M, Brown C, Carpentier AC, Langlois MF. (2011). Les étudiants en médecine sont-ils compétents pour soutenir des patients à modifier leurs habitudes de vie ?. 1re journée scientifique du Réseau canadien sur l’Obésité (RCO) Chapitre de l’Université de Sherbrooke. (Published).
• Labbe SM, Carpentier AC, Grenier-Larouche T, Guerin B, Lavallee E, Phoenix S, Turcotte E. (2011). Lifestyle changes is associated with a decreased of dietary fatty acid uptake in the heart and improved visceral adipose tissue uptake function in impaired glucose tolerance patients. Keystone Symposia on Lipid Biology and Lipotoxicity (E2). (Published).
• Twisk J, Greentree S, Petry H, de Wal J, Brisson D, Gagné C, Carpentier AC, Brunzell JD, Gaudet D. (2011). Lipoprotein Fractionation Studies In LPL Deficient Subjects, Before And After Administration Of Alipogene Tiparvovec (AAV1-LPLS447X Gene Therapy). Arteriosclerosis, Thrombosis and Vascular Biology 2011 Scientific Sessions. (Published).
• Hivert MF, Langlois MF, Carpentier AC, Doyon M, Brown C. (2011). Lower Leptin Level Is Associated with Increase in Insulin Resistance over Time in Healthy Young Adults, Independently of Change in Weight. American Diabetes Association's 71st Scientific Sessions. (Published).
• Biet M, Ton AT, Benrezzak O, Delabre JF, Morin N, Carpentier AC, Baillargeon JP, Gallo-Payet N, Langlois MF, Dumaine R. (2011). L’augmentation d’acides gras libres circulant augmente l’excitabilité cardiaque chez le chien. 53e Réunion annuelle du CRCQ. (Published).
• Gaudet D, Méthot J, Gagné C, Dery S, Tremblay K, de Wal J, Twisk J, Freidig A, Frisch F, Brisson D, Carpentier AC. (2011). Modifications in Triglyceride-Rich Lipoprotein Metabolism induced by Alipogene Tiparvovec (AAV1-LPLS447X Gene Therapy) correlate with clinical benefit in Patients with Lipoprotein Lipase Deficiency (LPLD). 2nd International Congress on Abdominal Obesity. (Published).
• Blondin DP, Labbé SM, Richard D, Turcotte EE, Carpentier AC, Haman F. (2011). Muscle recruitment and muscle-specific substrate uptake in cold-exposed humans evaluated by positron emission tomography coupled to computed tomography (PET/CT). 29th Annual Scientific Meeting of The Obesity Society. (Published).
• Ouellet V, Labbé SM, Blondin DP, Haman F, Turcotte E, Richard D, Carpentier AC. (2011). Métabolisme du tissu adipeux brun en réponse à une exposition au froid chez des hommes en santé. 3e Réunion annuelle de la plateforme COLosSUS. (Published).
• Grenier-Larouche T, Labbé SM, Rivard N, Carpentier AC. (2011). Palmitate induces endoplasmic reticulum (ER) stress in human adipose tissue stem cells (ADSC) and decreases adipocytes lipid accumulation. Keystone Symposia on Lipid Biology and Lipotoxicity (E2). (Published).
• Trottier A, Battista MC, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Perturbations métaboliques et endocriniennes précoces chez des adolescentes à haut risque de développer un syndrome des ovaires polykystiques. 3e Réunion annuelle de la plateforme COLosSUS. (Published).
• Trottier A, Battista MC, Moreau B, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Perturbations métaboliques et endocriniennes précoces chez des jeunes filles pré- et péripubertaires à haut risque de développer un syndrome des ovaires polykystiques. 13e Journée scientifique de l'Axe des maladies endocriniennes et métaboliques du Centre de recherche clinique Étienne-Le Bel. (Published).
• Kamga C, Carpentier AC, Langlois MF. (2011). Prise en charge du syndrome métabolique par une équipe interdisciplinaire d’obésité: une étude randomisée contrôlée. Matinée des résidents et fellows 2011, 45e Congrès annuel de l'AOGQ. (Published).
• Hivert MF, Xhignesse M, Brown C, Carpentier AC, Bilodeau S, Langlois MF. (2011). Profession MD – Lifestyle : an innovative program to increase medical school students’ awareness of their own lifestyle and competency to perform lifestyle counselling. CCME 2011. (Published).
• Blondin DP, Labbé SM, Richard D, Turcotte ÉE, Carpentier AC, Haman F. (2011). Recrutement et transport musculaire du 18Fluorodéoxyglucose (18FDG) et de l’acide 18Fluoro-6-thia-heptadécanoïque (8FTHA) lors d’une exposition au froid mesurés par tomodensitométrie couplée à la tomographie par émission de positrons (TEP/CT). 3e Réunion annuelle de la plateforme COLosSUS. (Published).
• Labbé SM, Grenier-Larouche T, Lavallée E, Phoenix S, Guérin, Turcotte E, Carpentier AC. (2011). Reduced adipose tissue and increased myocardial uptake of dietary fatty acid is associated with reduced left ventricular ejection fraction in subjects with impaired glucose tolerance. 2nd National Obesity Summit, Published in Canadian Journal of Diabetes 35 (2): 162. (Published).
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2011). Regulation of insulin sensitivity and fatty acids metabolism by endoplasmic reticulum stress. Canadian Diabetes Association. (Published).
• Bessi VL, Labbé SM, Huynh DN, Carpentier AC, Marleau S, Ong H. (2011). Rôle des sécrétines de l’hormone de croissance (GHS) dans la réduction des lésions myocardiques. 3e Réunion annuelle de la plateforme COLosSUS. (Published).
• Labbé SM, Ouellet V, Blondin DP, Haman F, Turcotte E, Richard D, Carpentier AC. (2011). Thermogénèse inductible par le froid dans le tissu adipeux brun chez les humains. 13e Journée scientifique de l'Axe des maladies endocriniennes et métaboliques du Centre de recherche clinique Étienne-Le Bel. (Published).
• Hivert MF, Brown C, Doyon M, Cuerrier JP, Carpentier AC, Langlois MF. (2010). An educational intervention combining small-group seminars and emails prevents weight gain in young adults over the first two years of university. Obesity 2010, 28th Annual Scientific Meeting. (Published).
• Shum M, Ménard S, Emond A, Grenier-Larouche T, Roberge C, Langlois MF, Baillargeon JP, Hallberg A, Carpentier AC, Gallo-Payet N. (2010). Angiotensin II-AT2 receptor stimulation with the selective nonpeptide agonist M24 (C21) prevents diet-induced insulin resistance in rats and modulates several aspects of adipocyte physiology. ENDO 2010. (Published).
• Richard D, Ouellet V, Labbé SM, Blondin DP, Turcotte E, Haman F, Carpentier AC. (2010). Brown adipose tissue in human. 11th International Congress on Obesity. (Published).
• Naimi F, Baptiste CG, Bellanger S, Raymond I, Gallo-Payet N, Battista MC, Benrezzak O, Carpentier AC, Baillargeon JP. (2010). Caractérisation de l’effet des acides gras libres sur l’hyperandrogénie dans un modèle animal. 6e Journée scientifique du 1er cycle de la Faculté de médecine et des sciences de la santé, Université de Sherbrooke. (Published).
• Grenier-Larouche T, Carpentier AC. (2010). Chemical Chaperone Rescue Lipotoxicity in Adipose Tissue Stem Cells. 2010 CDA/CSEM Professional Conference and Annual Meetings. (Published).
• Ouellet V, Labbé SM, Blondin DP, Haman F, Turcotte É, Richard D, Carpentier AC. (2010). Cold-activated brown adipose tissue metabolism in healthy men. Obesity 2010, 28th Annual Scientific Meeting. (Published).
• Blondin DP, Ouellet V, Carpentier AC, Richard D, Turcotte É, Haman F. (2010). Cold exposure methodology for investigating brown adipose tissue activation in humans. Obesity 2010, 28th Annual Scientific Meeting. (Published).
• Vanasse A, Carpentier AC, Courteau J, Drouin C, N. Asghari. (2010). Comparaison des profils thérapeutiques chez les patients diabétiques entre régions rurales et urbaines au Québec. Conférence du Centenaire de l’Association canadienne de santé publique (ACSP). (Published).
• Gaudet G, Frisch F, Méthot J, Déry S, Brisson D, Perron P, Essiembre C, Tremblay K, Tremblay G, de Wal J, Twisk J, Tang WW, van Deventer S, Carpentier AC. (2010). Effect of Gene Therapy with Alipogene Tiparvovec on Postprandial chylomicronemia in Patients with Severe HyperTG Due to LPL-Deficiency. Symposium on Postprandial Metabolism, Satellite to the 78th EAS Congress. (Published).
• Biet M, Ton AT, Delabre JF, Morin N, Benrezzak O, Carpentier AC, Baillargeon JP, Gallot-Payet N, Langlois MF, Dumaine R. (2010). Fatty rich diet increases cardiac excitability in dog. 21e Colloque des canaux ioniques. (Published).
• Twisk J, de Wal J, Petry H, Frisch F, Carpentier AC, Gagné C, Gaudet D. (2010). Gene therapy for LPL deficiency: monitoring clinical efficacy. 28th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT). (Published).
• Greentree S, Gaudet G, Brisson D, Méthot J, van den Bulk N, Twisk J, Carpentier AC. (2010). Gene therapy with alipogene tiparvovec (Glybera®) for patients with lipoprotein lipase deficiency results in long term expression and clinical benefit. EASD 40th Annual Meeting. (Published).
• Carpentier AC, Frisch F, Labbé SM, Méthot J, Gagné C, Déry S, Tremblay K, de Wal J, Twisk J, Freidig A, Brisson D, Gaudet D. (2010). Gene therapy with alipogene tiparvovec results in enhanced post-prandial clearance of low density chylomicrons in LPLD patients. Resuscitation Science Symposium (ReSS) AHA. (Published).
• Langlois F, Hivert MF, Carpentier AC, Brown C, Langlois MF. (2010). Ghrelin levels are associated with hunger but not with restraint, dishinibition or food behavior based on the Three-Factor Eating Questionnaire in healthy young adults. 11th International Congress on Obesity. (Published).
• Do DH, Belley-Côté EP, Carpentier AC, Lepage S, Nguyen M, Farand P. (2010). Glycemic response after maximal exercise stress test is not an alternative way to screen glucose intolerance and diabetes mellitus. Canadian Cardiovascular Congress. (Published).
• Bellabarba D, Perron P, Carpentier AC. (2010). How long could be the delay between a euthyroid graves ophtalmophathy and the eventual development of overt hyperthyroidism?. 14th International Thyroid Congress. (Published).
• Hivert MF, Brown C, Carpentier AC, Langlois MF. (2010). Insulin resistance is associated with increased leptin and C-reactive protein levels but not with reduced adiponectin levels in healthy young adults. 70th Scientific Sessions of the American Diabetes Association. (Published).
• Huynh DN, Bessi VL, Labbé SM, Carpentier AC, Ong H, Marleau S. (2010). Le tissue adipeux: cible de l’action du EP80317, un ligand sélectif du CD36 présentant des propriétés cardioprotectrices. 52e Réunion annuelle du CRCQ. (Published).
• Kamga C, Carpentier AC, Baillargeon JP, Ardilouze JL, Langlois MF. (2010). Management of the metabolic syndrome in an interdisciplinary obesity clinic: a randomized control trial. Journée de l’Accent sur la recherche APOG. (Published).
• Gaudet D, Méthot J, Gagné C, Déry S, Tremblay K, de Wal J, Twisk J, Freidig A, Frisch F, Brisson D, Carpentier AC. (2010). Modifications in Triglyceride-Rich Lipoprotein Metabolism induced by Alipogene Tiparvovec (AAV1-LPLS447X Gene Therapy) correlate with clinical benefit in Patients with Lipoprotein Lipase Deficiency (LPLD). Resuscitation Science Symposium (ReSS) AHA. (Published).
• Bessi VL, Huynh DN, Boulahya R, Proulx C, Labbé SM, Lubell WD, Carpentier AC, Ong H, Marleau S. (2010). Novel azapeptide ligands reduce myocardial infarct size after transient left coronary artery ligation in the mouse. Canadian Cardiovascular Congress. (Published).
• Grenier-Larouche T, Carpentier AC. (2010). Palmitate Induce Lipotoxicity of Adipose Tissue Stem Cells. 70th Scientific Sessions of the American Diabetes Association. (Published).

Autres contributions

Activités de collaboration internationale

• Canadian Leader. Netherlands. Canada-Netherlands Consortium of Research on Type 2 Diabetes (the TIMED Consortium).
• Merck consultant. United States of America. Merck Obesity Input Meeting.
• Mission Director. China.
• Member of the Scientific Advisory Board, Institut de cardio-métabolisme, Paris. France. Member of the Scientific Advisory Board of the Institute of Cardiometabolism and Nutrition (ICAN) in Paris.
• Advisory Editor Diabetes. United States of America. Advisory Editor for Diabetes (American Diabetes Association).
• Member of the Quebec delegation. United Kingdom. Quebec delegation to the symposium "Toward clinical and public health solutions to the epidemic of cardiometabolic diseases" in Cambridge and London.
• Member of the local Scientific Committee. Canada. International Chair on Cardiometabolic Risk 3rd ICAO Congress, Quebec City, Quebec, Canada July, 9-12, 2012.
• Consultant of HLS Therapeutics Inc. Canada. Advisory board and development, Montréal, QC, January 30, 2019.
• Member of Janssen National diabetes specialty advisory board, Orlando, FL, USA. United States of America. Member of Janssen National diabetes specialty advisory board, Orlando, FL, USA, June 26, 2018.
• Member of Janssen Regional advisory board, Québec city, Montréal. Canada. Member of Janssen Regional advisory board, Québec city and Montréal.
• Member of the organizing committee. France. Member of the organizing committee for the development of scientific activities to induce the participation of Quebecers to the Société francophone du diabète (SFD).
• Consultant HLS Therapeutics inc. Canada. Regional advisory board (virtual meeting).

Présentations

• (2024). Effects of the incretin hormones on adipose tissue browning and metabolic function. Merck Obesity Input Meeting. Miami, United States of America
• (2024). Faire « brunir » le tissu adipeux de l’homme est-il choix thérapeutique. Les journées Klotz « Adipocyte », Société Française d'Endocrinologie et de la Société Francophone du Diabète. Paris, France
• (2024). Le parcours de carrière d’un « ancien jeune » médecin endocrinologue en recherche translationnelle et clinique. Symposium de la médecine interne. Groupe d’intérêt en médecine interne de l’Université Laval (https://www.facebook.com/gimiUL). Québec, Canada
• (2024). The adipose-liver unit in cardiometabolic diseases: lessons from bariatric surgery. 2024 MODR Symposium, McMaster University. Hamilton, Canada
• (2024). The physiological relevance and therapeutic potential of brown and beige adipose tissues. Merck Obesity Input Meeting. Miami, United States of America
• (2023). Advances in tracer and molecular imaging methods of adipose tissue energy metabolism. ICAN Scientific Advisory Board. Paris, France
• (2023). Dysmétabolisme des tissus adipeux et maladies cardiométaboliques. Congrès annuel de la fédération hospitalo-universitaire IMPACT (Innovative Medicine for the Prevention an treAtment of Cardiovascular and meTabolic disease). Toulouse, France
• (2023). Endocrine debate : « Does activating brown fat contribute ton important metabolic benefits in humans. Endocrine Society’s Annual Meeting, ENDO 2023. Chicago, United States of America
• (2023). Première édition de la conférence de prestige Domenico Regoli : Insuline: Après 100 ans de découvertes, toujours d'actualité en recherche!. Journée de la recherche Gabriel Plaa 2023 du département de pharmacologie et physiologie de l’Université de Montréal. Montréal, Canada
• (2023). Y-a-t-il un rôle de la graisse brune dans les maladies cardiométaboliques chez l'homme?. Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM, Université Paul Sabatier URM1297. Toulouse, France
• (2023). Étendre les frontières de l'investigation du diabète et de l'obésité par l'imagerie moléculaire. Webinaire du Centre de formation médicale du Nouveau-Brunswick. Moncton, Canada
• (2022). Adipose tissue dysfunction: a target for the prevention and treatment of type 2 diabetes. Annual Diabetes CME Day. London, Canada
• (2022). Brown adipose tissue: a translational perspective. Henry Friesen Award Lecture, Canadian Society of Endocrinology and Metabolism Brown adipose tissue symposium. Calgary, Canada
• (2022). Brown adipose tissues, lipids and metabolism. Saltin International Graduate Course in Exercise and Clinical Physiology, Queen’s Landing. Niagara-On-The-Lake, Canada
• Dr Serge Lepage, cardiologue Dr Jean-François Belleau-Nantel, omnipraticien. (2022). Débat A-GLP1 vs I-SGLT2. Programme d’apprentissage virtuel NovoNordisk. Canada
• (2022). Fonction métabolique des tissus adipeux dans les maladies cardiométaboliques. Colloque de l’ACFAS « Obésité et santé : cibler le poids ou le mode de vie ». 89e Congrès de l’ACFAS. Canada
• (2022). Nouveautés en diabète. 22e Congrès annuel de la Société des sciences vasculaires du Québec. Montréal, Canada
• (2022). PET applications in Nutrition and Endocrinology. 2022 NORC Summer Imaging Workshop: Metabolic Imaging in Clinical and Translational Research. Denver, United States of America
• (2022). Quelques apprentissages de l’étude de la fonction des tissus adipeux en imagerie moléculaire. Réunions scientifiques, Institut de cadiologie de Montréal. Montréal, Canada
• (2022). Table ronde stratégique des experts québécois en cardiologique. HLS Therapeutics. Canada
• (2022). Targeting adipose tissue metabolic function for the treatment of cardiometabolic disorders. MAESTRIA Consortium Meeting. Maastricht, Netherlands
• (2022). The shapes of tracers: Applying positron emission tomography to energy metabolism. RACMEM 2022: Recent advances & controversies in the measurement of energy metabolism. Québec, Canada
• (2022). Élucidation des mécanismes anti-diabétiques de la chirurgie bariatrique par l’imagerie moléculaire. Réunion annuelle des départements de chirurgie et d’anesthésie de l’Université de Sherbrooke. Sherbrooke, Canada
• (2021). AVC et diabète: quoi de neuf?. 21e Congrès annuel de la Société des sciences vasculaires du Québec. Canada
• (2021). Brown adipose tissue: its relevance for human physiology and health. McGill University Health Center MeDiC (virtual conference). Montréal, Canada
• (2021). Diabète et AVC: quoi de neuf?. Société des sciences vasculaires du Québec "Diabète et AVC: nouveautés". Montréal, Canada
• (2021). Disordered adipose tissue metabolism in type 2 diabetes: a therapeutic target?. McGill University Health Center Endocrine Rounds (virtual conference). Montréal, Canada
• (2021). Insulin and adipose tissue fatty acids metabolism. EGIR-EASD Study Group Spring Virtual Meeting: Pancreatic hormones and organ cross talk: new insights 100 years after discovery of insulin. Rome, Italy
• (2021). National Institutes of Health Endocrine Training Program Rounds: Adipose tissue-mediated regulation of fatty acid fluxes in cardiometabolic disorders. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney. Bethesda, United States of America
• (2021). Rôle du métabolisme des acides gras des tissus adipeux dans les maladies cardiométaboliques. Grand Round of the Department of Medicine, Université de Sherbrooke. Sherbrooke, Canada
• (2021). The CIHR Canada – Netherlands Consortium on Type 2 Diabetes Research : the TIMED Consortium. The 2001 Diabetes Canada/CSEM Professional Conference, CIHR Symposium on the 100th Anniversary of the Discovery of Insulin. Canada
• (2021). What you need to know about adipose tissue metabolic dysfunction. Eli Lilly Symposium on adipose tissue dysfunction in obesity. Canada
• (2020). Diabète : de l'insuline aux nouvelles molécules... vers la thérapie génique?. Société des Sciences Vasculaires du Québec 20 ans en 2020. Montréal, Canada
• (2020). Imagerie du métabolisme des gras alimentaires dans le diabète de type 2: vers l'identification d'une nouvelle cible thérapeutique. Journée scientifique Jean-Marie Moutquin. Sherbrooke, Canada
• (2020). Le rôle clé des tissus adipeux dans le diabète et ses complications. Congrès 2020 Association Québécoise des Infirmières et Intervenants en Recherche Clinique. Bromont, Canada
• (2020). Mécanismes de la Rémission Rapide du Diabète de Type 2 Après la Chirurgie Bariatrique: Rôle du Métabolisme des Tissus Adipeux. Congrès virtuel sur les désordres cardiométaboliques et le diabète. Paris, Canada
• (2020). Postprandial Fatty Acid Metabolism in Metabolic Disease. 2020 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium. Universal city, United States of America
• (2019). Adipose tissue metabolism: implication for the liver. NAFLD symposium. Seville, Canada
• (2019). Brown fat in cardiometabolic health. 13th Annual Scientific Meeting of the Montreal Diabetes Research Centre. Montréal, Canada
• (2019). Futur du traitement du diabète : au-delà des inhibiteurs de SGL T2. 15es Journées Francophones de l’Insuffisance Cardiaque de la Société Française de Cardiologie. Rennes, France
• (2019). Imagerie moléculaire du métabolisme des tissus adipeux : occasions et défis pour la prévention et le traitement du diabète de type 2. Axe obésité, diabète de type 2 et métabolisme de l’IUCPQ. Québec, Canada
• (2019). Imaging of White and Brown Adipose Tissue Metabolism in Humans as a Target for the Prevention and Treatment of Type 2 Diabetes. Antaros Research Group. Sweden
• (2019). Implication du métabolisme des acides gras dans la rémission du diabète de type 2 après la chirurgie bariatrique. Symposium de chirurgie bariatrique de l’Université de Laval. Québec, Canada
• (2019). Using PET to Define Adipose Tissue and Muscle Nutrient Utilization. Obesity Week. Las Vegas, United States of America
• (2019). White and brown adipose tissues in dietary fatty acid partitioning in humans. 2nd CPH BAT International Conference. Copenhagen, Denmark
• (2018). Adipose tissue metabolic dysfunction in obesity and type 2 diabetes. International Congress on Obesity and Metabolic Syndrome (ICOMES). Seoul, Korea, South
• (2018). Critical review of the energy sources of brown adipose tissue thermogenesis in humans. American diabetes Association 78th Scientific Sessions Meeting Planning Committee. Orlando, United States of America
• (2018). Gestion du métabolisme par les tissus adipeux blancs et bruns dans le diabète de type 2 . Société Francophone du Diabète. Montréal, Canada
• (2018). La graisse brune : curiosité métabolique ou véritable cible thérapeutique?. Conférences hebdomadaires de l’IRCM (Institut de recherches cliniques de Montréal). Montréal, Canada
• (2018). Métabolisme cardiaque des acides gras et son implication dans le développement de la cardiomyopathie diabétique. 29e édition Rencontres de Cardiologie. Paris, France
• (2018). Nouveautés sur les fondations physiopathologiques du diabète de type 2. Congrès scientifique annuel de l’Association des médecins endocrinologues du Québec. Montréal, Canada
• (2018). Pharmacological activation of brown adipose tissue metabolism. Merck – FMSS Scientific Day. Sherbrooke, Canada
• (2018). Revue de l'année 2018 du laboratoire Carpentier. Endocrine Grand Round, division of Endocrinology. Sherbrooke, Canada
• (2018). Syndrome métabolique et ses répercussions cliniques chez la femme. Journées annuelles de ménopause de La Société canadienne de ménopause (SIGMA) et le groupe gynécocolpo. Saint-Sauveur, Canada
• (2017). Adipose tissue remodeling and cardiometabolic risk. FRQS Delegation in China for the development of Quebec-China collaborations in cardiology and cardiometabolic disorders. China
• (2017). Dietary fatty acid spillover to the heart : a novel target for the prevention and treatment of diabetic cardiomyopathy ?. 4th Banting & Best Diabetes Centre/Joslin Diabetes Center/University of Copenhagen Conference. Toronto, Canada
• (2017). Dysfonction des tissus adipeux et risque cardiométabolique. Conférences du département de pharmacologie et physiologie de l'Université de Montréal. Montreal, Canada
• (2017). Dérèglement métabolique et cardiovasculaire précoce dans le diabète de type 2 : quel rôle dans les démences neurodégénératives. Synergie franco-québécoise de l’Académie nationale de médecine : rencontres médicales et scientifiques France-Québec. Quebec, Canada
• (2017). Fatty acid metabolism in the human heart. 85th Annual Meeting of the European Atherosclerosis Society (EAS). Prague, Czechia
• (2017). TEP-IRM pour évaluer la dysrégulation métabolique : une influence majeure pour la maladie d'Alzheimer. Synergies franco-québécoises de l'Académie nationale de médecine (ANM) : Rencontres médicales et scientifiques France-Québec. Québec, Canada
• (2016). Adipose tissues: metabolic valves for an obesogenic environment. 2e Symposium de la Chaire JA DeSève, Institut de recherches cliniques de Montréal. Montreal, Canada
• (2016). Advances in molecular imaging for personalized nutrition and care for type 2 diabetes. Seminar Series fort he 2015-16, McGill University. Montréal, Canada
• (2016). Brown adipose tissue : is it relevant for caloric balance and pathophysiology in humans ?. Seminar Series for the 2015-16, McGill University Health Center. Montreal, Canada
• (2016). Brown adipose tissue metabolism in humans. Research Seminar Series - Sanford Burnham Prebys Medical Discovery Institute (at Lake Nona). United States of America
• (2016). Du stéthoscope au clamp jusqu'à l’anti-matière: un voyage en compagnie de William Osler, Ralph DeFronzo et Paul Dirac. Réunion scientifique annuelle 2016 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM), du Réseau de recherche en santé Cardiométabolique, Diabète et Obésité (CMDO) du FRQS et du Congrès Colossus, Prix des Fondateurs. Orford, Canada
• (2016). La recherche sur le diabète au CIUSS de l’Estrie CHUS : à la fine pointe et orientée vers le patient. Salon Santé – Diabète Brome-Missisquoi. Canada
• (2016). Mechanisms of T2DM relapse after bariatric surgery : it is restriction!. Annual Meeting of the Canadian Association of Bariatric Physicians and Surgeons. Toronto, Canada
• (2016). Molecular Imaging of Fatty Acids to Access Cardiometabolic Interventions. International Academy of Cardiovascular Sciences – Annual Meeting of the North American Section – Symposium 1 on Cardiovascular Dysfunction in Chronic Diabetes. Sherbrooke, Canada
• (2016). Organ-specific dietary fatty metabolism : unravelling the complex links between the diet and type 2 diabetes (Medicine Grand Round) and Brown adipose tissue (BAT) : is it relevant for caloric balance and pathophysiology in humans ?. Visiting Professor Event McMaster University/St. Joseph's Healthcare. Hamilton, Canada
• (2016). Towards precision nutritional medicine using molecular imaging. MUHC Endocrine Combined Rounds. Montreal, Canada
• (2015). Adipose tissue metabolism and its contribution to metabolic health. The Physiological Society Summer meeting. Cardiff, United Kingdom
• (2015). Caloric restriction is the main mechanism of remission of T2DM after bariatric surgery. 4th Canadian Obesity Summit. Toronto, Canada
• (2015). Ectopic fat deposition in type 2 diabetes: cardiometabolic imaging studies. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases. Québec, Canada
• (2015). Gaps and new opportunities in clinical practice: targeting the mechanisms of metabolic dysfunctions?. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases. Québec, Canada
• (2015). Glucolipotoxicity: a figment of our imagination ?. IDF 2015, 23rd World Diabetes Congress 2015. Vancouver, Canada
• (2015). Imagerie du métabolisme des gras alimentaires: vers une médecine nutritionnelle personnalisée. Programme des conférences scientifiques du vendredi midi, CHU Ste-Justine. Montreal, Canada
• (2015). Imaging of type 2 diabetes. Toronto Knowledge Translation Working Group and the RxMD Leaders for Life planning committee. Toronto, Canada
• (2015). La chirurgie pour le diabète de type 2 : une solution à long terme ?. 23e Réunion scientifique annuelle de la Société québécoise d’hypertension artérielle. Montréal, Canada
• (2015). Métabolisme cardiaque des lipides alimentaires : le chemin vers l’insuffisance cardiaque chez le patient diabétique ?. Séminaires multidisciplinaires de cardiologie de l’Institut universitaire de cardiologie et de pneumologie de Québec. Canada
• (2015). Nouveaux outils moléculaires d’exploration des mécanismes liant la nutrition aux complications cardiométaboliques. Conférences scientifiques du CRCHUM. Montreal, Canada
• (2015). Tracers and molecular imaging to reveal mechanisms of type 2 diabetes-related outcomes in humans. CIHR INMD Advisory Board Meeting, Sherbrooke. Canada
• (2015). Une carrière en recherche translationnelle : être prêt, au bon endroit et au bon moment. 23e Réunion scientifique annuelle Société Québécoise d’Hypertension Artérielle (SQHA). Montréal, Canada
• (2015). Vers une médecine de précision des maladies métaboliques à l'aide de la physiologie intégrative et de l'imagerie moléculaire. Symposium du 35ème anniversaire du CRCHUS. Sherbrooke, Canada
• (2014). Métabolisme postprandial des acides gras alimentaires et métabolisme cardiaque. Échanges Scientifiques, IRCM. Montréal, Canada
• (2013). Abnormal dietary fatty acid partitioning in pre-diabetes: implications for cardiac function in humans. Quebec-UK symposium Clinical and public health solutions to the obesity epidemic. Cambridge, United Kingdom
• (2012). Mécanismes d'accumulation ectopique des graisses dans le diabète de type 2. ICAN Institut de Cardiométabolisme & Nutrition. Paris, France